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CHAPTER I 
 
 
INTRODUCTION 
 
. 
 
Over a few decades, the healthcare domain has been using IT for varied purposes such as storing 
patients visit details, cost, insurance details and more. Healthcare data are massive, data 
warehousing, knowledge management techniques can contribute to decision support systems in 
healthcare. The task of data collection and storage has improved extensively not just in terms of 
data collection, but also in its volume. Analyzing such an enormous amount of data would require 
specialized tools to analyze it, as manual data analysis would be tedious for such voluminous 
data. Medical informatics  incorporate such needs by the use of statistical pattern recognition, 
machine learning, and visualization tools that would support the analysis of the data that are 
encoded in the given data, using a new interdisciplinary field of knowledge discovery in 
databases (KDD) (Frawley, Piatetsky-Shapiro, & Matheus, 1992). The method of data collection, 
analysis and formulation of knowledge out of these recognized patterns and visualization is 
referred to as data mining (Cios & Moore, 2002). Knowledge discovery in databases one of the 
main uses of data mining. Data mining tends to work well with such massive data. According to 
Frawley et al., 1992 “Data mining is the non-trivial extraction of implicit previously unknown 
and potentially useful information about data
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     According to Coorevits et al., 2013, the clinical research supported by electronic health 
records (EHR) is the upcoming new era. Since, millions of patients undergo treatments, 
equivalent or surplus amount of data is generated for these patients. Using these EHR specific 
knowledge and clinically actionable analysis can be generated. Various statistical, machine 
learning and computational techniques can be used to generate this specific knowledge, pattern 
recognition, clustering, generating models based on these EHR.  
     One of the challenging tasks in data mining is to use data mining to foresee the outcomes of a 
particular disease. One of those outcomes is survival. Survival analysis in the medical prognosis 
involves utilizing a set of parameters to predict the patients’ health. The historic data of these 
patients is used to predict survivability. 
     According to the Centers for Diseases Control and Prevention, USA (2015) the number of 
deaths in 2014 were 2,596,993. Out of these 2,596,993 the top five death causing diseases were: 
1. Heart disease: 611,105 deaths   
2. Cancer: 584,881 deaths  
3. Chronic lower respiratory diseases: 149,205 deaths  
4. Accidents (unintentional injuries): 130,557 deaths  
5. Stroke(cerebrovascular diseases): 128,978 deaths 
Cancer is the second death causing disease and 1,658,370 new cases of cancer are estimated and 
out of these 589,430 people will die from the disease (National Cancer Institute 2015). Table 1 
show the list of estimated new cases and estimated deaths due to different cancers.  
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Cancer type Estimated new cases Estimated deaths 
Bladder 74,000 16,000 
Breast (Female- Male) 231,840 - 2,350 40,290-440 
Colon and Rectal (combined) 132,700 49,700 
Endometrial (Ovarian) 54,870 10,170 
Kidney (Renal Cell and Renal 
Pelvis) 
61,560 14,080 
 
Table.1 Cancer types with estimated cases. 
     This research focuses on predicting ovarian cancer survivability. The reasons that motivated 
this research on are: 
1. The serious effects of ovarian cancer 
2. Limited prior studies in the field 
3. Potential of data mining technique and  
4. A desire to further understand the nature of ovarian cancer  
1.1 About Ovarian Cancer 
Ovarian cancer is a disease that is caused by malignant or cancerous cell found in the 
reproductive glands of women. According to American Cancer Society, 2015: “Ovarian cancer 
begins in the ovaries. Ovaries are reproductive glands found only in females (women). The 
ovaries produce eggs (ova) for reproduction. The eggs travel through the fallopian tubes into the 
uterus where the fertilized egg implants and develops into a fetus. The ovaries are also the main 
source of the female hormones estrogen and progesterone. One ovary is on each side of the uterus 
in the pelvis.” As shown in Fig.1. 
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Fig.1 Ovarian Cancer. (http://www.ovarydisease.com/p/ovarian-cancer.html) 
1.2 Signs and Symptoms 
Ovarian cancer is difficult to detect during the early stages. In most cases the signs and symptoms 
are seen in advanced stages. The potential signs and symptoms may include: 
 Abdominal bloating or swelling 
 Pain in the belly or pelvis 
 Frequent urination 
 Loss of appetite or feeling full too soon 
There are other symptoms which if they occur more than 12 times a month, may also be ovarian 
cancer symptoms: 
 Fatigue 
 Constipation 
 Menstrual changes 
 Back pain 
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1.3 Types of ovarian cancer  
Ovaries are made of three types of cell; each type cell can develop its own tumor. These tumors 
can be classified into benign (non-cancerous) and malignant (cancerous). The benign type of 
tumor never spreads beyond the ovaries. However, it can be treated by removing either the ovary 
or the part of the ovary which contains the tumor. The malignant type of tumor can spread to the 
other parts of the body and can be fatal. The three types of tumors are as follows: 
a) Epithelial tumors 
Epithelial tumor starts from the epithelial cells: that cover the outer surface of the ovaries. The 
epithelial tumor are further classified into three sub types: benign (non-cancerous), low malignant 
potential (low potential cancer) and malignant (high potential cancer). About 90% of ovarian 
cancers are epithelial tumors. 
b) Stromal tumors 
Stromal tumors develop from the connective tissue cells that produce female hormones. This is a 
very rare class of tumors; it accounts for about 1% of ovarian cancers. 
c) Germ cell tumors 
The germ cell tumors begin from the cells that produce eggs. According to the American Cancer 
Society (2015), this type of tumor accounts for less than 2% of ovarian cancers and may be 
benign, but some can be life threatening. 
1.4 Staging of Cancer 
Based on clinical examination and the findings at laparotomy, an assessment is made for the 
disease. Staging is very important because based on the stage each cancer type will need different 
treatments. Staging for the cancer needs to be done accurately, because if not, then cancer that has 
6 
 
spread outside the marked stage of that particular stage could be missed. The method used for 
staging is the International Federation of Gynecology and Obstetrics (FIGO) system. Using this 
system, the tumor first needs to be classified based on the results of surgery. The extent of the 
primary tumor is coded as T. The letter N is used to represent absence or presence of metastasis 
to nearby lymph nodes. And the presence or absence of distant metastasis is represented by the 
letter M. Once the patient’s tumor is classified based on these letters, this information is 
combined with a Roman numeral form of coding, called stage grouping, which goes from stage I 
(least advanced stage) to stage IV (most advanced stage (Society of Gynecologic Oncology, 
2014): 
 Stage I          Growth limited to ovaries  
 Stage I I        Growth involving one or both ovaries with pelvic extension. 
 Stage I I I     Growth involving one or both ovaries with intraperitoneal metastases 
outside the pelvis 
 Stage I V     Growth involving one or both ovaries with distant metastases  
1.5 Causes and Risk Factors 
Risk factors provide information about person’s chances of acquiring the disease. These risk 
factors don’t tell us everything, it is difficult to say how much did a factor contribute towards the 
cancer. A few factors are (Centers for Disease Control and Prevention, 2015; MedicineNet.com, 
2015): 
 Age: The higher the age, the higher the risk of developing ovarian cancer. Half of all 
ovarian cancers are found in women who are 63 and older. 
 Obesity: Women with a BMI (Body Mass Index) of at least 30 have a higher risk of 
developing ovarian cancer. 
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 Estrogen therapy and hormone therapy: Recent studies suggest that the risk of developing 
ovarian cancer increases when estrogens is used after menopause. 
 Family history of ovarian cancer, breast cancer, or colorectal cancer: Family history of 
some other cancer such as breast cancer, or colorectal cancer increases the risk of ovarian 
cancer. 
 Family cancer syndromes: 5-10 % of ovarian cancer are due to family cancer syndromes, 
where mutation in the genes BRCA1 and BRCA2 are responsible for most inherited 
ovarian cancer. 
 Fertility drugs: Some researchers have found using fertility drug clomiphene citrate 
(Clomid®) for a period longer than one year increases the risk of ovarian cancer. 
1.6 Diagnosis  
Diagnosis of ovarian cancer is possible. Methods for diagnosis include imaging test like 
computed tomography (CT) scans, magnetic resonance imaging (MRI) scans and ultrasound 
studies can confirm whether a pelvic mass is present. Other tests like laparoscopy, colonoscopy, 
biopsy, and blood test can help if a woman shows symptoms of ovarian cancer. According to the 
American Cancer Society, 2015 about 20% of ovarian cancer are found at an early stage. There 
are a few ways to find ovarian cancer early(Cancer.Net, 2015; National Ovarian Cancer 
Coalition, 2015)  
 Regular women’s health exams:  A regular health exam including the pelvic exam may 
help identify any cancerous tumor in the pelvic area. 
 Visit the doctor if symptoms are seen: During the early stages, cancer doesn’t cause many 
symptoms, but if symptoms are present over a longer period of time, like 12 times during 
the course of a month, gynecologists suggest seeking medical attention. 
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 Screening test for ovarian cancer: Screening tests help to find cancer even for people who 
don’t show symptoms of ovarian cancer. There has been a lot of research so far to find 
the best way for screening ovarian cancer, but there is no single method that has been 
completely reliable. However, CA-125 blood test and transvaginal ultrasound (TVUS) 
are the most often used tests. TVUS can help find tumor in the ovary, but it can’t show if 
the tumor is benign or malignant. When TVUS is used there can be cases where the 
tumor found might not be cancerous. CA-125 is used to test the protein level in the blood. 
The problem with using this test is there can be other conditions that can cause high 
levels of CA-125. Studies found that TVUS and CA-125 are used a lot for screening and 
testing, but it did not lower the number of deaths caused by ovarian cancer.  
According to the American Cancer Society (2015), in the United States about 21,290 women will 
receive a diagnosis of ovarian cancer in 2015. About 14,180 U.S. women are estimated to die 
from ovarian cancer in 2015. This study deals with all types of Malignant Neoplasm of Ovary 
listed in Table 2. The diagnosis type for all of the listed malignant neoplasm of ovary is ICD9. 
According to Centers for Disease Control and Prevention, 2015 (ICD-9-CM) is: 
“The International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) 
is based on the World Health Organization's Ninth Revision, International Classification of 
Diseases (ICD-9). ICD-9-CM is the official system of assigning codes to diagnoses and 
procedures associated with hospital utilization in the United States.” 
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Diagnosis codes Diagnosis description 
183 Malignant Neoplasm of Ovary and Other Uterine Adnexa 
183.0 Malignant Neoplasm of Ovary 
183.2 Malignant Neoplasm of Fallopian Tube 
183.3 Malignant Neoplasm of Broad Ligament of Uterus 
183.4 Malignant Neoplasm of Parametrium 
183.5 Malignant Neoplasm of Round Ligament of Uterus 
183.8 Malignant Neoplasm of Other Specified Sites of Uterine Adnexa 
183.9 Malignant Neoplasm of Uterine Adnexa, Unspecified 
  
Table.2 Types of Malignant Neoplasm of Ovaries 
1.7 Problem Statement 
The aim of this study is to investigate patterns or factors that influence the survival of ovarian 
cancer patients using predictive modeling techniques in data mining. Using predictive modeling 
the study aims at answering a few research questions like: 
 Are there any particular sets of patterns that are important to the survival of the patient? 
 Given a set of non-modifiable factors (race of the patient, admission type of the patient, 
length of stay and so on.), is it possible to predict whether or not an ovarian cancer 
patient would survive or not survive? Accepting model accuracy of more than 75%. 
 Evaluating the predictive models using balanced and unbalance datasets. Thus, suggest 
which technique to use while using a real world unbalanced data.  
1.8 Research Objectives 
Ovarian cancer has not been a great focus of research using data mining techniques. While other 
cancers like prostate cancer, breast cancer have already been studied, it is important to study 
ovarian cancer. In addition, as large number of studies have investigated the early detection of 
ovarian cancer and numerous studies have published that symptoms may not occur until the last 
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stage of ovarian cancer. As there are no diagnostic tools to detect ovarian cancer, symptoms 
remain the most important factor for its detection. The study aims at: 
1. Providing a different approach to predict the survival of ovarian cancer patients using 
machine-learning techniques given a set of non-modifiable factors vary from race of the 
patient, admission type of the patient, length of stay and so on.  
2. To approach this issue use descriptive profiling: finding patterns from the data. 
3. Test various hypothesis on the data.  
4. Using predictive modeling approach, which is also known as supervised prediction or 
supervised learning. This technique uses two sets of variables called inputs i.e. predictors, 
features, explanatory variables and other set called targets i.e. outcome, dependent 
variable. It can also be said that predictive modeling outputs are the predictions or 
guesses of the given set of inputs or predictor variables. To do so this research aims to 
take advantage of the available historic data of the patients by using three classification 
data mining techniques like Decision trees, Artificial Neural Network- Multilayer 
Percepton (MLP) and Artificial Neural Network-Radial Basis Function (RBF).  
5. In addition, find which machine-learning techniques performs better using balanced and 
unbalance datasets.  
6. Accepting a model that predicts ovarian cancer survival with an accuracy of more than 
80%
11 
 
CHAPTER II 
 
 
LITERATURE REVIEW 
 
 
 
There are a large number of studies that are investigating the early detection of ovarian cancer. 
Numerous studies have published that symptoms may not occur until the last stage of ovarian 
cancer. As there are no diagnostic tools to detect ovarian cancer, symptoms remain the most 
important factor for its detection. However, two studies done in the United States and United 
Kingdom studying the screening of ovarian cancer found that the CA-125 protein level in blood 
detected more cancer. The results of this screening didn’t lead to any better outcome than for 
those who weren’t screened.  
     New ways of treatment including new testing methods are also being studied by researchers. A 
study carried on germline mutations in a gene on chromosome 17q known as BRCA1 show that 
BRCA1 genes are responsible for a large proportion of inherited breast cancer and ovarian cancer 
(Ford, Easton, Bishop, Narod, & Goldgar, 1994). A study on survival benefit showed that second-
look laparotomy after completion of first line single agent cisplatin chemotherapy did not show 
any benefits for survival for patients with epithelial ovarian cancer(Luesley et al., 1988). One 
study on effective screening of ovarian cancer shows that if the cancer is screened before it  
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metastasizes, the detection of preclinical disease at an early stage would improve the overall 
survival (Bast Jr et al., 2002). A case based study on 150 patients studying the influence of 
fertility and oral contraceptives on the risk of ovarian cancer on patients under the age of 50, 
shows that women who had an immediate intolerance to oral contraceptive showed increased risk   
of ovarian cancer(Casagrande et al., 1979).  
     There are studies that focus only a certain age groups, such as one study on analysis of 
outcomes with neoadjuvant chemotherapy or primary cytoreduction that was performed on 
elderly ovarian cancer patients. The study found that the patient population aged 80+ didn’t show 
any variation in complication rate for chemotherapy and surgical related complications when 
compared to those aged 65-79. This study concludes there didn’t appear to be any impact of the 
choice of initial treatment on the survival when these decisions were used in a selective manner 
(McLean et al., 2010). Elderly patients with advanced ovarian cancer receive less frequent 
chemotherapy was the conclusion from Sundarajan et al.,2002 done on a patients over age 65 
(Sundararajan, Hershman, Grann, Jacobson, & Neugut, 2002). 
     Further studies based on chemotherapy for elderly patients were carried out by Eisenhauer et 
al.,2007, who concluded that patients aged 65+ or 65 showed no differences on initial response, 
platinum resistance, PFS and OS as compared to other younger patients. It was also noted in the 
study that elderly women who can handle primary cytoreductive surgery should receive platinum-
taxane chemotherapy along with it (Eisenhauer et al., 2007). Most studies did not find any 
variation in complications produced by chemotherapy amongst different age groups. While some 
studies did find a particular age group to handle a certain type of chemotherapy well. Because of 
such contradictory outcomes, it is difficult to estimate if a particular age group would perform    
better than the other.  
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     Various studies have been done on ovarian cancer using data mining one of which is applying 
data mining criteria to investigate 52 proteins being good candidates as ovarian cancer 
biomarkers(Kuk et al., 2009). A study on chronic disease prognosis and diagnosis system uses 
case based reasoning and data mining. This results for this study talks about how in the 
knowledge creating phase data mining techniques, the decision tree induction algorithm and the 
case association are used to discover implicit results from the data. This study uses rule which are 
stored in rule base for the particular chronic diseases prognosis. Based on those rules probabilities 
for new cases are calculated. These new cases will then trigger the case based reasoning 
mechanism to support cases from the library for that particular chronic diseases prognosis. The 
most important contribution of this study is that it shows how helpful implicit rules are which are 
based on the technique of data mining process(Huang, Chen, & Lee, 2007). 
     Jeetha & Malathi, 2013 intended to observe performance of Artificial Neural Network (ANN) 
over genetic algorithm on diagnosis of ovarian cancer. The conclusion of this study was to use 
ANN along with genetic algorithm and propose a method for refinement and categorizing the 
ovarian cancer with kind, spreading, and normal tissue. Since studies have focused on how a 
genetic algorithm performs when compared to machine learning technique, it is interesting to 
learn how these techniques be used as an advantage to learn about survival of ovarian cancer 
patients using non-modifiable factors. 
      Kumar & Bishoni, 2013 studied Reptree, BRF network, and simple logistic for diagnosis 
system, while concentrating on non-modifiable risk factors and modifiable risk factors for breast 
cancer survivability. Non-modifiable factors such as age, gender, menstrual history, age at 
menarche and age at menopause and modifable factors like BMI, age at first child birth, number 
of years of breast feeding, alcohol, diet and number of abortion. This study suggests that simple 
logistic can be used to obtain fast automatic diagnostic system for other diseases. Breast cancer 
survivability has had a lot of focus over the last few years. One of such studies is by Delen et al., 
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2005, the method used by this study is to use three data mining algorithms decision trees and 
artificial neural networks along with statistical method logistic regression. To compare the 
performance of these models a 10 fold cross validation strategy is used. The study finds decision 
tree (C5) to be the best predictor on the holdout sample with an accuracy of 93.6%, while logistic 
regressions show the worst accuracy of 89.2%. Similar study on breast cancer survivability on 
SEER dataset investigates three data mining techniques: the Naïve Bayes, the back-propagated 
neural network, and the C4.5 decision tree algorithms. The results found C4.5 algorithm has a 
much better performance than the other two techniques(Bellaachia & Guven, 2006).  
     According to Ahemad & Shereen, 2012 while comparing single decision tree (SDT), boosted 
decision tree (BDT) and decision tree forest (DTF) for the detection of breast cancer during 
validation phase of analysis DTF achieved 97.51 %, which was superior to SDT (95.75 %) and 
BDT (97.07 %) classifiers. Another study compares seven common algorithms (Logistic 
Regression model, Artificial Neural Network (ANN), Naive Bayes, Bayes Net, Decision Trees 
with naive Bayes, Decision Trees (ID3) and Decision Trees (J48)) besides the most widely used 
statistical method (Logistic Regression model) to find an optimal model to predict breast cancer 
survival rate. The study finds Logistic Regression model to be the optimal model with the highest 
accuracy of 85.8±0.2%. A study on predicting coronary artery disease (CAD) where strategies 
like logistic regression (LR), classification and regression tree (CART), multi-layer perceptron 
(MLP), radial basis function (RBF), and self-organizing feature maps (SOFM) are compared in 
order to predict if the patient has CAD. The comparison is made on the ROC curve, Hierarchical 
Cluster Analysis (HCA), and Multidimensional Scaling (MDS). The results of this study suggest 
MLP to be the best technique with an area under the curve for ROC as 0.783(Kurt, Ture, & 
Kurum, 2008).  
      Data mining has also been used in studying the performance of classification techniques for 
predicating risk of hypertension compares three decision trees, four statistical algorithms, and two 
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neural networks. The study concludes that ANN- MLP and RBF procedures, performed better 
than other techniques in predicting hypertension.(Ture, Kurt, Turhan Kurum, & Ozdamar, 2005). 
Stark & Pfeiffer,1999 compared logistic regression (LR), classification technique ID3, C4.5, 
CHAID, and CART.  These techniques were compared on veterinary epidemiology dataset, they 
found classification techniques are well-suited for exploratory data analysis. Another study by 
King, Feng, & Sutherland, 1995 compared machine learning techniques like CART, C4.5, 
NewID,AC2, ITrule, Cal5 and CN2, statistics Naïve Bayes, k-nearest neighbor, kernel density, 
linear discriminant, quadratic discriminant, LR, projection suit and Bayesian networks and neural 
networks back propogation and RBF. These techniques were compared on twelve datasets with 
respect to large world problem. 
     Ovarian cancer has not been a thorough matter of research using data mining techniques; 
while other cancers like prostate cancer, breast cancer have already been studied in depth. In 
addition, large number of studies have investigated the early detection of ovarian cancer and 
many of them have concluded that symptoms may not occur until the last stage. As there are no 
diagnostic tools to detect ovarian cancer, symptoms remain the most important factor. That is 
why this study uses non-modifiable factors to predict ovarian cancer survivability by using 
similar comparative strategies on a real world dataset.
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CHAPTER III 
 
 
METHODOLOGY 
 
 
 
3.1 Introduction 
Data driven research in cancer is now becoming more prominent and useful, since most of the 
cancer research is usually clinical or biological in nature. The term survival analysis evolved from 
the initial studies, where the interest was death. Survival analysis in the medical prognosis field 
uses historic data to predict survivability. It can also be said that medical prognosis involves the 
use of prediction models where a patient’s information of the disease is used to estimate his/her 
health. “Survival” as many dictionaries describe it is a state or fact of continuing to live or exist. 
Survival analysis also has been studied using events like death, recovery, relapse, and length of 
time an individual is in the hospital.  Many researchers define a survival period as a 10 year 
duration, but over the years the definition has improved. 
     For defining “Survival” for the purpose of this study Table.3 has been used (shows the list of 
“discharge classifier”) and for “Non-Survival” or “Expired” Table.4 has been used (shows the list 
of “Filtered Discharged Classifiers”) which are derived from the dataset provided by CHSI 
Cerner Health Facts®. The discharge classifiers are indicator of the state of the patient’s health 
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status (Table.3) also lists the indicators of their health after they are discharged home “Expired at 
home. Medicaid only, hospice” (Table.4).  
No. DISCHARGED CLASSIFIER 
1 Discharged to home 
2 Discharged/transferred to another short term hospital 
3 Discharged/transferred to SNF 
4 Discharged/transferred to ICF 
5 Discharged/transferred to another type of inpatient care institution 
6 Discharged/transferred to home with home health service 
7 Discharged/transferred to home under care of Home IV provider 
8 Discharged/transferred within this institution to Medicare approved swing bed 
9 Discharged/transferred/referred another institution for outpatient services 
10 Discharged/transferred/referred to this institution for outpatient services 
11 Discharged/transferred to another rehab fac including rehab units of a hospital  
12 Discharged/transferred to a long term care hospital. 
13 
Discharged/transferred to a nursing facility certified under Medicaid but not certified 
under Medicare. 
14 
Discharged/transferred to another Type of Health Care Institution not Defined 
Elsewhere 
15 Discharged/transferred to a federal health care facility. 
16 
Discharged/transferred/referred to a psychiatric hospital of psychiatric distinct part 
unit of a hospital 
17 Discharged/transferred to a Critical Access Hospital (CAH). 
18 Discharged/Transferred to a designated cancer center or childrens hospital 
19 Discharged for Other Reasons 
20 Discharged to Care of Family/Friend(s) 
21 Discharged to Care of Paid Caregiver 
22 Discharged to Court/ Law Enforcement/Jail 
23 Discharged to Other Facility per Legal Guidelines 
 
Table.3 Types of Discharged Classifiers 
To define non-survival the dataset uses classifiers as listed in the table. All the different types of 
“expired” classifiers were later coded as “expired” for analysis (Table 4). 
No.  DISCHARGED CLASSIFIER 
1 Expired 
2 Expired at home. Medicaid only, hospice. 
3 Expired in a medical facility. Medicaid only, hospice. 
4 Expired, place unknown. Medicaid only, hospice. 
Table.4 Filtered Discharged Classifiers 
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Cerner data warehouse was established with Health Insurance Portability and Accountability Act 
(HIPAA)–compliant operating policies and procedures using statistical methods for de-
identification of clinical and financial information.  
“The HIPAA Privacy Rule provides federal protections for individually identifiable health 
information held by covered entities and their business associates and gives patients an array of 
rights with respect to that information. At the same time, the Privacy Rule is balanced so that it 
permits the disclosure of health information needed for patient care and other important 
purposes.” (U.S. Department of Health & Human Services) 
     In simpler terms, once a patient are discharged home, HIPAA prevents the hospital from using 
patient’s information like address, phone number. Hence, it is difficult to keep track of a patient’s 
health once they have been discharged to home. Therefore, this is a limitation of this study that 
once a patient was been discharged to home there is a possibility that families do not report the 
status of patient’s health. Thus, such cases patient are been considered to survive. Accounting all 
of these factors and considering the in-depth status of patients while in hospital for the purpose of 
this using dataset provided by CHSI Cerner Health Facts® the “survival” of ovarian cancer 
patients has been defined as using the classifier “discharged home” as survived. The “discharged 
home” classifier chosen to mark a completely recovered patient because all other classifiers point 
to a patient who has not fully recovered (Table.3). While all the different types of “expired” 
classifiers were later coded as “expired” for analysis (Table.4). 
3.2 CRISP- DM Approach 
In order to proceed with analysis of the data it is very important to have a data mining process. 
There are various data mining methodologies; these methodologies attempt to shape the way a 
data analyst approaches the steps to perform the data mining tasks. The two major methodologies 
that are most used are SEMMA and CRISP- DM. SEMMA, which stands for Sample, Explore, 
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Modify, Model, Assess, has been developed by SAS Institute. On the other hand, Cross Industry 
Standard Process for Data Mining (CRISP- DM) was developed by software vendors and industry 
users of data mining. For this study, the data mining process that is being used is a Cross Industry 
Standard Process for Data Mining (CRISP- DM) approach. This approach consists of six phases 
(see Fig 3.1): 
  
 
Fig.3.1 CRISP-DM process (http://www.sv-europe.com/crisp-dm-methodology/) 
3.2.1. Business Understanding 
This is the initial phase of the process where the business question or the question of interest is 
discovered. In this study the research question is, what factors contribute to survivability of an 
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ovarian cancer patient? Also, are there any patterns a patient needs to pay attention to in terms of 
getting early cancer treatment? 
3.2.2. Data Understanding 
The given data is examined for the appropriate data type and knowledge is acquired about the 
various tables and variables available in the dataset. 
3.2.3. Data Preparation 
To prepare the data for analysis the following sub steps were used: 
a) Data Access 
The study uses the data from the Center for Health System Innovation (CHSI) provided by Cerner 
Health Facts. The Cerner Health Facts dataset is the largest relational database on healthcare. This 
database is a comprehensive source of de-identified, real-world, HIPAA-compliant data.  
     The database consists of more than 50 million unique patients, more than 2.4 billion laboratory 
results, more than 84 million acute admissions, emergency and ambulatory visits, more than 14 
years of detailed pharmacy, laboratory, billing and registration data and more than 295 million 
orders for nearly 4,500 drugs by name and brand.   
     The data for ovarian cancer patients is extracted using the SQL Server Management Studio 
2012. SQL is a standard language for accessing and manipulating databases. Since, Cerner 
Health Facts® is a Relational Database Management System the basis to use it is SQL. The flow 
chart Fig.3.2 shows the steps followed in the extraction process. There were more than 50 million 
unique patients, more than 14 years of detailed pharmacy, laboratory, billing and registration data 
and more than 295 million orders of drugs by name and brand. These were filtered and 46,792 
ovarian cancer patients were considered. Later, these were brought down to 32,350 patients’ 
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records which had the desired information related to survivability of these patients. Out of these 
3,566 were unique patients, are useful for analysis of this study. These records were obtained 
using SQL and SAS software when required. Clauses, expressions, statements etc. were widely 
used in the data extraction process from SQL server. 
Fig.3.2 Process flow of data extraction  
b) Data Consolidation 
The data was acquired in a text (.txt) file and was then brought into SAS enterprise Guide (6.1) 
this text file was converted into a .sas7data file. There were no major issues while consolidating 
the data. 
c) Data Cleaning 
The raw text file consisted of 80 variables. The dataset had more than one Encounter_ID, 
Hospital_ID, Patient_ID, Dischg_disp_ID, Procedure_ID etc. so the duplicate columns were 
50 Million 
Patients 
•Total Patients in 
the 
Datawarehouse 
46,792 Ovarian 
Cancer Patients 
14,442 records 
deleted due to 
missing values 
35,250 patient 
records after data 
cleaning 
3,566 unique 
patients
•Unique 
records used 
for predictive 
analysis
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deleted and only one of each column was kept. Other variables like age_in_months, 
age_in_weeks, and age_in_days etc. were dropped as all the records had all “0” values, this is 
observed using histograms and analyzing the mean, minimum and maximum. Since the data set 
also consisted of the variable age_in_years the other age related variables didn’t serve any 
purpose. Further, initial data exploration was conducted on each variable through descriptive 
statistics. For interval variables, the mean, minimum, maximum, and missing values were studied. 
Histograms were used to analyze the distribution of these interval variables. To check if there 
were any outliers box and whisker plots were used for interval variables. Very few records 
consisted of missing values. Once all the duplicate columns were removed and outliers were 
analyzed another step was essential to use the data for analysis. Since, each record in the data set 
captures the encounters of the patients visit to the facility. Which implies there can be multiple 
encounters for a particular patient.  
     As this study focuses on the survivability it was important to have single encounters of these 
patients. To do so the records were aggregated for the same person using the patient_sk variable 
that is unique for a particular patient. There are other data challenges that needs to be accounted 
for like the curse of dimensionality. The curse of dimensionality, an expression coined by 
mathematician Richard Bellman, refers to the exponential increase in data required to densely 
populate space as the dimension increases. In case of a large number of inputs the curse of 
dimensionality doesn’t fit the model so well. In this study, this issue was handled by reducing the 
total number of inputs from 80 to 45. The problem of redundancy occurs when the input doesn’t 
give any new information that has not already been explained. The dataset did have redundant 
variables for example: dischg_disp_id and dischg_disp_code these two variables explain the same 
information about the patients’ discharge status similarly other variables were discarded based on 
redundancy. After cleaning of data the variable list was brought down to 47 (Appendix). 
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3.2.4. Modeling 
Data mining is also about model generation. This step involves using actual modeling techniques 
that can be used to address the research question. Data mining models can be generated for three 
types of tasks like: descriptive profiling, directed profiling and prediction. The descriptive models 
or descriptive profiling gives insight into what the data does. Outputs of these models and 
hypothesis testing generate graphs, charts and summary statistics of the data. Direct profiling is 
when the target and the inputs for the models are from the same time frame. Prediction is finding 
patterns in the data from one period that are capable of explaining outcomes in a later period. This 
study focuses on both Predictive modeling and descriptive profiling.  
3.2.5. Evaluation 
The task in this step is to evaluate the generated model and go back and forth to reach the desired 
outcome for the research question.  
3.2.6. Deployment 
The last step is report generation and summary of the project. 
3.3 Descriptive Profiling 
To analyze data descriptively tools like histograms, bar charts, pie charts, and cross tabulation 
were used to see patterns or distribution of values in the fields. All of these techniques provide a 
better insight into how the variables are distributed and how diverse the data is. These techniques 
all help in drawing conclusions on what factors can be more significant, least significant and 
more. However, further analysis is always required to confirm these results. 
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3.4 Predictive Modeling 
Following the CRISP-DM approach helps a data analyst follow a sequence of steps that would 
help get standardized steps and results. There a few data mining techniques where the model 
complexity increases as the number of terms increases, or the number of leaf increases. The 
standard strategy for the model assessment of the generalized data is splitting. The dataset is split 
into three types of datasets: training, validation, and test.A portion of the raw dataset is used to 
build the models this dataset is called the training dataset. The validation dataset is used to 
monitor and tune the performance of the built model. The test dataset is used to estimate the 
generalization of the generated models. For the purpose of this study, the data is partitioned into - 
66% Training dataset and 33% Validation dataset. Since, this partition is a popular partition ratio 
for most of the data mining applications.  
3.4.1 Balancing Technique 
After the data preparation process the dataset is found to have relatively fewer instances of 
patients who have “not survived” i.e variable survival_code= “0” with 188 patients compared to 
the number of patients who have “survived” i.e variable survival_code= “1” with 3,378 patients. 
So it can be said that the “survived” class label is the majority class and “not survived” is the 
minority class. The total number of records in the data is 3,566 records. A dataset is said to be 
imbalanced when the minority class contributes less than 35% (Li & Sun, 2012). Since, the 
minority numbers in the dataset used for this study are less than 35% this dataset can be said to be 
an imbalanced dataset. Many studies have found when an imbalanced data is used the results 
would tend to biased towards the majority class, while not being so accurate about the minority 
class. There are three methods used to handle an imbalanced dataset: Random Under-Sampling 
(RUS), Random Over –Sampling (ROS), and Synthetic minority over sampling technique 
(SMOTE). 
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a) Random Under-Sampling (RUS) 
 In RUS strategy, cases from the majority classes are randomly removed without replacement so 
that there are approximately the same number of cases in the minority class as in the majority 
class. 
b)  Random Over-Sampling (ROS) 
In this method, the minority classes are randomly added to the dataset without replacement until 
they are roughly of the same number as that of the majority class. 
c)  Synthetic minority over sampling technique (SMOTE) 
In the SMOTE strategy, k nearest neighbors for each of the minority examples are found. Then 
these k nearest neighbors are randomly selected based on the over sampling rate. This generates a 
new synthetic case between the minority class and each of the found k nearest neighbors. The 
process of generating synthetic case is repeated until the number of cases are approximately the 
same in both classes (Chawla, Bowyer, Hall, & Kegelmeyer, 2002). 
     To balance the imbalanced data, for this study the method used is Random over-sampling 
method. The minority classes “not survived” i.e variable survival_code= “0” are randomly added 
to the dataset without replacement until they are roughly of the same number as that of the 
majority class “survived” i.e variable survival_code= “1”. After applying this method, the total 
number of records in the imbalanced data goes up to 6,574 records. 
3.4.2 Predictive Modeling Classification Method: 
In this study, three classification methods are used: Decision trees, Artificial Neural Network- 
MLP and Artificial Neural Network- RBF since these are powerful and popular for both 
classification and prediction in the domain of predictive modeling. These techniques are used 
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along with k-fold cross validation technique is used to minimize the overfitting or bias in these 
predictive modeling techniques  
i. Decision Trees 
Decision trees can be defined as structures that can be used to develop a graphical user interface 
where large data is divided into successively smaller sets of records. Decision trees are governed 
by a set of rules that are used to produce successively smaller sets of records of the larger records. 
This technique is used to perform both classification and estimation tasks. The division of larger 
records (parent node) is called splitting and the successively smaller sets of records are called 
child nodes. The top of the tree is the root node, while the subsequent rules are interior nodes, and 
the end of the node or the node with only one connection are leaf nodes. Decision trees run on 
split search algorithms using different strategies to make splits. Since, the variable under 
observation is a binary variable “1” or “0”, we use “decision” to assess the subtree model. The 
advantages of using decision tree is they are not so complex structures. They are not sensitive to 
usual values (outliers) in the data and thus provide better performance. They reveal a lot about the 
data and require less data preparation.  
ii. Artificial Neural Network 
Artificial Neural Network (ANN) are powerful tools and mathematical models used for pattern 
recognition and modeling. ANN behave in a similar fashion as that of the biological neurons 
found in nature. They are usually referred to as Neural Network and are used for classification, 
prediction, and clustering. NN consists for numerous formulations the study focuses on two 
formulation the multilayered perceptron (MLP) and radial basis function (RBF).  
   MLP is feed forward neural network (Fig.3.3) that is trained by the back propagation algorithm. 
It consists of several layers of computing units or neurons. Each unit or neuron belongs to the 
neural network that has a non-linear activation function.MLP contains one or more hidden layers 
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these layers are: input layer, hidden layer, and output layer. MLP networks are supervised 
techniques, they learns from the input data as to how to transform to desired response. Inputs for 
each layer are the previous layer inputs multiplied by the activation synaptic weights, summed 
and transformed by the activation function. These outputs are then sent to the next hidden layer. 
 
Fig.3.3 Graphical representation of NN with multilayers 
 
RBF networks are non-linear and have a static bell shaped function. In this case, the activation of 
a hidden neuron or layer is based on the distance between the input vector and the center vector. 
It consists of input layer, hidden layer where there is a non-linear transformation from the input 
space to the hidden space and the output layer that generates the output for the network. In case of 
RBF divides the space into hyperspheres instead of using hyperplanes as in MLP. Thus, in this 
case the inputs are used to determine the basis function, which is followed by the finding weights 
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of the parameters found from the inputs. MLP minimizes the sum of squares of errors, which is 
also used in RBF. 
 
Fig.3.4 Graphical representation of NN with activation function 
     The advantages of using ANN is they usually perform better than the other models due to their 
complex structures. They are not sensitive to unusual values (outliers) in the data and thus 
provide better performance. The disadvantages of using ANN can be lack of clarity, because the 
network generated is not always easy to interpret. Since ANN are not capable of selecting inputs 
by themselves, they would use all the inputs present in the initial data. Sometimes due to large 
number of variables the ANN algorithm would not converge, so for the algorithm to converge 
ANN is used in combination with Logistic regression. Logistic regression in this case selects 
input variables for ANN algorithm and uses them for further analysis. Regression technique is 
explained as follows. 
iii. Regression 
Regression models are the oldest prediction models: they create a specific association structure 
between inputs and targets. They use mathematical equations to predict cases using input 
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variables. There are two forms of regressions: linear and logistic regression. In a linear regression 
modeling approach, the target is predicted using simple combination of the input variables. Linear 
regression uses numeric input variables to predict the target numeric variable. They don’t handle 
the cases with missing values as well as decision trees and neural networks. To use the cases 
which have missing values these missing values would need to be replaced or imputated. 
Imputation would use the mean, median or the mode to replace the missing values (blanks) with 
either of these values based on the variable type. Logistic regression are very much similar to 
linear regression. They use link function transformation for the target variable. As in linear 
regression, a linear combination of the inputs is used, but these inputs generate a logit score, the 
log of odds of primary outcome. The logistic function is inverse of the logit function. To predict 
the estimates, the logit equation for the target variables needs to be solved in this case. Regression 
also uses three sequential selection methods to select useful input variables. These three methods 
are:  forward selection, backward selection and stepwise selection. 
a) Forward Selection 
The model starts with a base line model predicted by using overall average target values of all 
cases. The algorithm uses this base line model to search for new inputs for the models. A variable 
is added to the sequence only if the base line model shows a significant improvement in this 
complexity. Qualifier for the improvement is done on the bases of p-value, thus adding inputs 
increases the model’s overall fit statistics. The algorithm terminates when there is no significant 
improvement in this complexity or the p-value. The p-value for this algorithm is predefined entry 
cutoff defined by the user based on their needs. 
b) Backward Selection 
In case of the backward selection the model starts with almost all possible input variables. The 
inputs are removed from the model and thus the complexity of the model decreases. Removing 
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inputs decreases the model’s overall fit statistics. Qualifier for this method is done on the bases of 
p-value that is removing inputs with the highest p-value. The algorithm terminates when there is 
no significant improvement in this complexity or the p-value. The p-value for this algorithm is 
predefined stay cutoff defined by the user based on their needs. 
c) Stepwise Selection 
The model combines both the forward and the backward selection process. The model starts with 
a base line model predicted by using overall average target values of all cases, just like in the case 
of forward selection. A variable is added to the sequence only if the p-value is smallest and below 
the entry cutoff. Once this is done there is a reevaluation of the overall statistics of the model. 
Qualifier for the improvement is done on the bases of p-value, thus if the p-value of the added 
inputs increases the stay cutoff, the input is removed from the model. The variable once removed 
can be added and once the variable is added it can be removed too. The algorithm terminates 
when the variables that are added have greater p-values than predefined entry cutoff and also the 
p-value is below the predefined stay cutoff. . 
3.3  k-Fold Cross Validation 
A k-fold cross validation technique is used to minimize the overfitting or bias in the predictive 
modeling techniques used in this study. k-Fold cross validation is used with decision tree and 
neural network with MLP and RBF to generate more flexible models to reduce overfitting or 
underfitting. The complete dataset R is randomly split into k-mutually exclusive subsets or folds 
of approximately equal size (R1, R2, R3…, Rk). In classification model each of the k-subsets are 
trained and tested k times.  One of the k-subsets is used as the test set and the other k-1 subsets 
are used as training dataset.  Then the overall accuracy is calculated as the average of the k 
individual accuracy measures. All the machine learning techniques in this study use 10- fold cross 
validation. 
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3.4 Performance Evaluation Techniques 
Evaluation of classification methods is one of the most important step in data mining. The most 
techniques are confusion matrix, learning curves and receiver operating curves (ROC). The 
confusion matrix shows the number of correct and incorrect prediction made by the prediction 
models. True positive (TP) are the case which are predicted correctly by the model, and actually 
the patient has survived. True negatives (TN) are those case that are predicted expired by the 
model, but actual is the patient has survived. False Positive are cases when model predicts the 
patient survived, but the patient actually expired (Type I error). False negative are cases when 
prediction of the model is the patient expired, but they actually have survived (Type I I error). 
Accuracy is the proportion of the total number of all the correct prediction of the model. It is 
calculated as the ratio between the total numbers of correctly classified cases to the overall 
number of cases under consideration.  
Accuracy = TP +TN / (TP+TN+FP+FN) 
 
Sensitivity is the proportion of positive cases, which are correctly classified i.e. the percentage of 
patients who expired and are classified correctly as expired.  
Sensitivity = TP / (TP+FN)                                                                
                         
Specificity is the proportion of negative cases, which are correctly classified i.e. the percentage of 
patients who survived and are classified correctly as survived.  
Specificity = TP / (TN+FP)                                                               
                         
Where TP, TN, FP and FN denote true positives, true negatives, false positives and false 
negatives. 
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CHAPTER IV 
 
 
DESCRIPTIVE PROFILING 
 
 
 
The findings from descriptive analysis of the raw data set are discussed in this chapter. Section 1 
discusses the variable analysis and section 2 discusses various hypothesis testing. 
4.1 Variable Analysis 
Variable Analysis: Different Malignant Neoplasm of Ovaries 
Table 4.1 shows the distribution of ovarian cancer patients with different types of diagnosis 
codes. On observation, it was found there are 95% females with malignant neoplasm of ovary in 
this study. The remaining 5% of the females have been classified with others types of malignant 
neoplasms amongst which malignant neoplasm of fallopian tube is the second highest percent i.e. 
3 %. A much fewer number of females i.e. 0.03% are diagnosed with malignant neoplasm of 
ovary and other uterine adnexa.
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Table.4.1 Frequency distribution for different Malignant Neoplasm of Ovaries 
 
Variable Analysis: Age 
Table 4.2 shows the age distribution of the patients. It can be observed that the average age of the 
ovarian cancer patients in this study is 60 years old, while there seem to be a more number of 65 
years old women in the case of this study. The dataset shows similar patterns observed by the 
SEER Cancer Statistics, which finds ovarian cancer rates highest in women aged 55-64 years. In 
this case, the mode is 65 years i.e. there are higher number of women who are aged 65 years.  The 
age of the patients varies in the range from 0- 90 years. Also from the bar chart Fig.4.1, it can be 
said 63 year is the median age of this population.  
 
 
Table.4.2 Variable analysis: Age of a patient. 
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Fig.4.1 Distribution Chart of age in years  
 
 
Fig.4.2 Survival rate based on Age 
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Fig.4.3 Bar Chart for Relative Percentages of age 
Based on survival rate age group 16-20 years and 0-15 years shows better outcomes than other 
age groups (Fig.4.2). Figure 4.3 shows the relative percentages of age in years. The age group 61-
70 years shows the maximum likelihood of having ovarian cancer, which is followed by age 
group 71-80. The relative percentage of different groups regarding a variable is calculated as: 
Number of ovarian cancer patients in a group/ Number of all female patients (not 
just those with ovarian cancer) in the Cerner data set in that particular group.  
Variable Analysis: Marital Status 
Table 4.3 clearly shows that “Married” women constitute 46% of the total ovarian cancer 
patients, while 17% “Single” ovarian cancer patients are single females.  
 
Table.4.3 Variable analysis: Marital Status. 
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Pie chart Fig.4.4 shows a pictorial representation of the table above. Patients who have marital 
status life partner are 0.07% of all the types of marital status. As we see, the proportion of 
“Married” women is more than double that of “Single” women. Pie chart Fig.4.4 also confirms 
that there are 509 widowed women in this study, while women who live with life partners are the 
lowest with 3 in count. 
Fig.4.4 Pie Chart of Marital Status  
Figure 4.5 clearly points out the survival rate of ovarian cancer patients that “Married” women 
have 95% survival rate, while “Legally separated” women have 87% survival rate. 
Fig.4.5 Survival rate based on Marital Status  
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Fig.4.6 Bar Chart of Relative Percentages of Marital Status 
Bar chart Fig.4.6 shows a pictorial representation of the relative percentages of various marital 
status. The graph shows that “Widowed” women have the maximum likelihood of having ovarian 
cancer. Although an exact conclusion cannot be drawn on this graph alone. Figure 4.7 shows the 
distribution of survived patients with different marital status. 
 
Fig.4.7 Bar Chart of Marital Status vs Survived =1  
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Variable Analysis: Race 
The next graph Fig.4.8 deals with the distribution of race in the dataset. It is observed from the 
graph that there are 2835 females who are “Caucasian”. “African American” women 462 in count 
are the second highest in this dataset.  “Pacific Islander” women are the lowest in count. The data 
shows similar patterns as observed by SEER Cancer Statistics, which shows 13.0 new cases per 
100,000 people are “White” and “Black” are 9.8 of new case per 100,000 people by 
race/ethnicity. Figure 4.10 shows relative percentages in this study, since this study consists of 
only Cerner’s datasets small portion of patients the percentages are relatively small. Also, if the 
females are healthy they would not be in the dataset. Figure 4.9 shows the survival rate of ovarian 
cancer patients based on race for this dataset. “Caucasian” women show a survival rate of 94%, 
while “African American” show 92% survival rate.  
 
 
 
 
 
 
 
 
39 
 
Fig.4.8 Bar Chart of Race  
 
 
 
Fig.4.9 Survival rate based on Race 
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Fig.4.10 Bar Chart of Relative Percentages of Race 
Figure 4.10 shows the relative percentage distribution of patients with different races. It is 
interesting to note that “Pacific Islander” and “Asian” women have relatively high likelihood of 
having ovarian cancer compared to women of “Caucasian” and other ethnicities. Figure 4.11 
shows the distribution of survived patients with different race. 
 
Fig.4.11 Bar Chart of Race vs Survived =1  
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Variable Analysis: Patient Type 
The data also captures the information whether the encounter (visit) was an inpatient, emergency 
room or outpatient visit. Table 4.4 shows the distribution of these patient visits. Most of the 
patient visits are “Inpatient” visits i.e. 2033 patients out of 3566, which is 57.01 % of the total 
patients. The “Emergency” visits are 3% of total patient visits. Figure 4.12 shows “Inpatients” 
have a survival rate of 91% and “Preadmit” shows survival rate of 90%.  
Table.4.4 Variable analysis: Patient type 
Fig.4.12 Survival rate based on Patient type 
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Fig.4.13 Bar Chart of Relative Percentages of Patient type 
 
Figure 4.13 clearly points out “Inpatient” show higher likelihood of having ovarian cancer in 
comparison to other patient type. It also shows “Outpatient” are half of that of “Inpatient”. Figure 
4.14 shows the distribution of survived patients with different patient type status. 
 
Fig.4.14 Bar Chart of Patient type vs Survived =1 
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Variable Analysis: Admission Source and Present On Admit 
The admissions of these patients’ visits are captured by the admission source used for the 
patients. It can be said that, 70 % of ovarian cancer patients are referred by physicians for further 
examination of their condition. On the other hand, there are 12% clinic referrals and 8 % 
emergency room visit, in the case of this study. The unknown in this case can be a case of 
missing data, or if the source of admission has not been captured while the data is collected. Also, 
80% of the times the presence of ovarian cancer is unknown while the patient has been admitted 
to the healthcare organization. This is justified by the table 4.6: 
Table.4.5 Frequency distribution for different Admission sources 
 
 
Fig.4.15 Survival rate based on Admission sources 
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Fig.4.16 Bar Chart of Relative Percentages of Admission sources 
Figure 4.16 shows “Physician Referral” is the most frequent admission source of ovarian cancer, 
while “Clinic Referral” are just 11% of the total admission type. Figure 4.17 shows the 
distribution of survived patients with different admission sources. 
 
 
Fig.4.17 Bar Chart of Admission Source vs Survived =1  
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Table.4.6 Frequency distribution for Ovarian Cancer patients with Present on admit 
 
Variable Analysis: Admission Type 
The pie chart (Fig. 4.18) shows distribution of the variable admission type that captures 
information on patient visits. It can be said that, 2,227 out of 3,566 of ovarian cancer patients are 
patients for whom the decision to admit has been made. On the other hand, there are 425 patients 
who are emergency case and 270 are urgent cases. 
 
Fig.4.18 Pie Chart of Admission type  
Based on the survival rate patients admitted in “Emergency” show a survival rate of 70%, while 
patients admitted “Urgent” show 81% survival rate (Fig.4.19). 
46 
 
 
Fig.4.19 Survival rate based on Admission type 
 
 
Fig.4.20 Bar Chart of Relative Percentages of Admission type 
Figure 4.20 shows the decision to admit ovarian cancer patients has already made and this can 
also be said from previous graphs where “Physician Referral” is the most frequent admission. 
Physician apply for patient’s admission and thus the decision to admit such patients was made 
before they are admitted to the hospital. One of the reason why “Elective” admission type is 
higher as compared to other admission types. Figure 4.21 shows the distribution of survived 
patients with different admission type. 
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Fig.4.21 Bar Chart of Admission type vs Survived =1 
Variable Analysis: Care Setting type 
Pie chart Fig 4.22 shows various care-setting types. It can be said that, the care setting is 
undefined for 1,346 out of 3,566 patients, while 438 patients are sent to oncology.104 patients are 
in the emergency room and 115 patients in ambulatory unit. Finally, 203 patients are sent for 
radiology. 
Fig.4.22 Pie Chart of Care-setting  
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Fig.4.23 Survival rate based on Care-setting 
 
 
Fig.4.24 Bar Chart of Relative Percentages of Care-setting 
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Fig 4.24 shows the maximum likelihood for care setting is for patients in “Surgery-Orthopedics” 
& “Oncology”. Patients in “Special Procedures Room” also have a high likelihood of having 
ovarian cancer. Figure 4.25 shows the distribution of survived patients with different care setting 
types.  
Fig.4.25 Pie Chart of Relative Percentages of Care-setting vs Survived =1  
Variable Analysis: Urban Rural Status 
The dataset provides information of the Cerner’s facility being in the “Urban” region or the 
“Rural” region. It gives an indication of where the patient might belong to in terms of its “Urban” 
“Rural” status. Pie chart Fig.4.26 shows there are 3558 women out of 3566 women who belong to 
or visit the “Urban” facilities of Cerner hospital. While only 8 women belong to “Rural” 
facilities. 
Fig.4.26 Pie Chart of Urban Rural Status of Ovarian Cancer patients 
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Fig.4.27 Survival rate based on Urban vs Rural Status 
 
Fig.4.28 Bar Chart of Relative Percentages of Urban vs Rural Status  
Figure 4.28 shows that number of patients admitted to urban areas is four times more than rural 
i.e. women in “Urban” area show higher likelihood of having ovarian cancer. Figure 4.29 shows 
the distribution of survived patients with different urban rural status. Based on survival rate 
women in “Rural” area show better results than “Urban” area. 
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Fig.4.29 Bar Chart of Urban Rural Status vs Survived =1  
Variable Analysis: Census Region 
Pie chart Fig 4.30 deals with the distribution of ovarian cancer patients in the entire US where the 
Cerner facilities are located. Cerner dataset consists of four census regions in which the facility is 
located South (East South Central, South Atlantic, and West South Central), Midwest (East North 
Central, and West North Central), West (Mountain, and Pacific), and Northeast(New England, 
and Middle Atlantic). As the pie chart, shows there are 1321 patients out of 3566 that belong to 
the South (East South Central, South Atlantic, and West South Central) region. The next to this is 
the Midwest (East North Central, and West North Central) region with a population of 1024 
women  and the West (Mountain, and Pacific) region has the least number of ovarian cancer 
patients i.e. 517 women. 
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Fig.4.30 Pie Chart of Census Region for Ovarian Cancer patients 
 
Fig.4.31 Survival rate based on Census Region 
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Fig.4.32 Bar Chart of Relative Percentages of Census Region 
Figure 4.32 shows “South” region show higher likelihood of having ovarian cancer, which is 
more than double that of “Northeast” region. Figure 4.33 shows the distribution of survived 
patients with different census regions. 
 
Fig.4.33 Bar Chart of Census Region vs Survived =1  
Variable Analysis: Census Division 
For the Cerner’s dataset there are 9 census divisions in which the 4 regions are divided. South 
(East South Central, South Atlantic, and West South Central), Midwest (East North Central, and 
West North Central), West (Mountain, and Pacific), and Northeast (New England, and Middle 
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Atlantic). The census division is an indicator of which division each facility resides. The table 4.7 
shows these divisions. 
 
 
Table.4.7 List of Census Divisions 
Fig.4.34 Pie Chart of Census division for Ovarian Cancer patients 
 
The pie chart fig.4.34 shows census division “6” South (DE, DC, FL, GA, MD, NC, SC, VA, 
WV) has the highest concentration of ovarian cancer patient i.e. 751. Census Division “2” has the 
second highest concentration of 513 patients in Middle Atlantic (NJ, NY, and PA).  Census 
Census Division States 
1 New England (CT, ME, MA, NH, RI, VT) 
2 Middle Atlantic (NJ, NY, PA) 
3 West North Central (IA, KS, NE, MN, MO, ND, SD) 
4 East North Central (IL, IN, MI, OH, WI) 
5 East South (AL, KY, MS, TN) 
6 South (DE, DC, FL, GA, MD, NC, SC, VA, WV) 
7 West South Central (AR, LA, OK, TX) 
8 Mountain (AZ, CO, ID, MT, NV, NM, UT, WY) 
9 Pacific (AK, CA, HI, OR, WA) 
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Division “1” constitutes of 511 patients in New England (CT, ME, MA, NH, RI, VT) relatively 
0.06%. While census division “9” constitutes of 461 patients from Pacific (AK, CA, HI, OR, 
WA).  East South (AL, KY, MS, TN) census division of “5” constitutes 453 patients. “4” East 
North Central (IL, IN, MI, OH, WI) constitutes 403 patients and Mountain (AZ, CO, ID, MT, 
NV, NM, UT, and WY) census division “8” has the least count of ovarian cancer patients i.e. 56 
out of 3566 patients.  
Fig.4.35 Survival rate based on Census division 
 
Fig.4.36 Bar Chart of Relative Percentages of Census division 
Figure 4.36 shows remarkably high number of patients in division 6(DE, DC, FL, GA, MD, NC, 
SC, VA, WV) i.e. Division 6 show higher likelihood of having ovarian cancer. The pattern in 
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these states is reflective of their population. Figure 4.37 shows the distribution of survived 
patients with different census divisions. 
 
Fig.4.37 Pie Chart of Census Division vs Survived =1 
Variable Analysis: Bed Size Range 
The dataset captures the information of the various categories of bed sizes that define the size of 
the hospital a patient visited. The pie chart fig.4.28 has the bed size categories of the hospital. The 
bed size categories vary from <5 to 500+ i.e. hospital consists of number of beds from <5 to 
500+. The hospital having a bed size category of 300-499 has the most patient counts of 1590, 
while the second most frequent bed size category of the hospital is 200-299 with a patient count 
of 703 patients. 6-99 category has 175 patients. While the largest category 500+ has a patient 
count of 664 patients and the least size, < 5 has 48 patients.  
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Fig.4.38 Pie Chart of Bed size range used for Ovarian Cancer patients 
 
Fig.4.39 Survival rate based on Bed size range 
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Fig.4.40 Bar Chart of Relative Percentages of Bed size range 
Figure 4.40 shows relative percentages of different bed size range. It is clear from the graph that 
patients visiting hospitals having bed size ‘300-499’ have maximum likelihood of having cancer 
followed by ‘100-199’.  Figure 4.41 shows the distribution of survived patients with different bed 
size range. 
Fig.4.41 Pie Chart of Bed Size range vs Survived =1 
Variable Analysis: Payer Type 
The payer type of each patient too have been captured in the dataset (Table 4.8). There are 36.17 
% patient whose payer type is “Medicare”, followed by “Blue Cross/Blue Shield” with 14.55 % 
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i.e. 519 patients. Only 3 patients or 0.08% patients are “Self-insured” and approximately, 0.17 % 
are “Worker’s Compensation” type of payers.  
Table.4.8 Variable analysis: Payer type 
 
Fig.4.42 Survival rate based on Payer type 
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Fig.4.42 Bar Chart of Relative Percentages of Payer type 
Figure 4.42 shows relative percentages of different payer types. It is clear from the graph ‘PPO’ 
patients show higher likelihood of having ovarian cancer  followed by ‘Medicare’. A very high 
number of patients also fall under the payer type “Self pay”.  Figure 4.43 shows the distribution 
of survived patients with different payer type. 
 
Fig.4.43 Survival rate based on Payer type 
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Fig.4.44 Pie Chart of Payer type vs Survived =1 
 
Variable Analysis: Total Charges 
Table 4.9 shows the total charges billed to the patients. As observed, the mean for total charges 
billed to ovarian cancer patients is $15584.46.  While it varies from $0 to a $738668.30, one of 
the reason for this variation could be the payer type of the patient. 
Table.4.9 Variable analysis: Total charges billed 
Variable Analysis: Length of Stay 
Table 4.10 shows the length of stay of a patient. It clearly shows the average number of days a 
person is in hospital is 3.5 days.  
Table.4.10 Variable analysis: Length of Stay of a patient 
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4.2 Hypothesis Testing 
Hypothesis Testing: Survival vs Type of Healthcare Care Setting. 
In the later part of this chapter, the findings from hypothesis testing are been discussed. All of the 
hypothesis have been tested at a significance level of 5 %. First hypothesis under consideration is, 
the null hypothesis that the survival of the patient is independent of healthcare type being an acute 
care setting. This null hypothesis was tested by looking at the Likelihood Ratio Chi-Square. As 
the evidence shows (Table 4.11), the Likelihood Ratio Chi-Square is greater than significance 
level of 5%, so the null hypothesis can’t be rejected. Thus, it can be said that the survival of the 
patient is independent of healthcare type being an acute care setting. The strength of this 
association is a weak association, which can be stated by the Contingency Coefficient for this 
test. 
H0 = Survival of the patient is independent of the type of healthcare being an acute care setting. 
Ha = Survival of the patient is dependent of the type of healthcare being an acute care setting. 
 
Table.4.11 Statistics for table for Survival vs type of healthcare care setting. 
     From the cross tabulation table (Table 4.12) it is said that there are 99.61% women that were 
admitted to care setting type acute, while 0.39 % women are admitted to non-acute caresetting 
type. The percentage of women that survived who were admitted to care setting type acute are 
99.59%.  
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Table.4.12 Cross Tabulation: Survival vs type of healthcare care setting 
Hypothesis Testing: Survival vs Bed Size Category of the Hospital 
The next null hypothesis is to find an association between the bed size category of the hospital 
and survival. The null hypothesis in this case is survival of the patient is independent of the bed 
size used for the patient. As evidence shows (Table 4.13), the Likelihood Ratio Chi-Square is less 
than the significance level of 5%, so the null hypothesis is rejected. Rejecting the null hypothesis 
means the alternative hypothesis is true. The alternative hypothesis in this case is survival of the 
patient is dependent on the bed size category of the hospital. Thus, there is an association between 
survival and the bed size category of the hospital. The variables show a weak association 
evidenced by Contingency Coefficient. 
H0 = Survival of the patient is independent of the bed size category of the hospital.  
Ha = Survival of the patient is dependent of the bed size category of the hospital.  
     From the cross tabulation table (Table 4.13) it is said that there are 44.59% women that were 
admitted to hospital with bed size range of 300-499, while 19.71 % women are admitted to 
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hospital with bed size range of 200-299. The percentage of women that survived who were 
admitted to hospital with bed size range of 300-499 are 45.44%, while 29.26% were expired. 
19.80 % women survived out of all the patients that were admitted to hospital with bed size range 
of 200-299, while 18.09% women expired in that category. <5 category constitutes 1.35% women 
and 100-199, 10.82 % women.  
 
Table.4.13 Cross Tabulation: Bed size range vs Survival code 
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Table.4.14 Statistics for table of Bed size range by Survival code 
 
Hypothesis Testing: Survival vs Census Region 
The next test looks at whether survival and the census region of where the patient belongs have 
any association. The null hypothesis is that survival of the patient is independent of the census 
region of where the patient lives. The Likelihood Ratio Chi-Square shows (Table 4.16) the chi-
square probability to be less than significance level of 5%, thus the null hypothesis was rejected. 
This implies the alternative hypothesis is true; survival of the patient is dependent on the census 
region where the patient lives. It can be thus, concluded that there is an association between 
survival and census region. The strength of this association is a weak association, this can be said 
based on the Contingency Coefficient for this test.  
H0 = Survival of the patient is independent of the census region of where the patient lives. 
Ha = Survival of the patient is dependent on the census region of where the patient lives. 
     Cross tabulation table shows (Table 4.15) it is said that there are 37.04% women that belong to 
South region, while 28.72 % women are from Northeast. The percentage of women that survived 
who are from the South region are 36.26%, while 51.06% were expired. 28.74% women survived 
were from Northeast, while 28.19% women expired in that category. 19.74% women are in 
Midwest 20.10 % women survived and 13.30% women expired. While, there are 14.50% women 
from West out of which 14.89% survived and 7.45 % expired. 
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Table.4.15 Cross Tabulation: Census Region vs Survival code 
 
 
Table.4.16 Statistics for table of Census Region by Survival code 
 
Hypothesis Testing: Survival vs Race 
Another test looks at the association between survival and the race of the patient. The null 
hypothesis of survival of the patient is independent of the race to which the patient belongs. 
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Likelihood Ratio Chi-Square show (Table 4.17) the chi-square is less than the significance level 
of 5%, so the null hypothesis is rejected. Rejecting the null hypothesis means the alternative 
hypothesis is true. The alternative hypothesis in this case is survival of the patient is dependent on 
the race to which the patient belongs. Thus, it can be inferred that there is a relationship between 
the between survival and the race of the patient. Yet, the variables show a weak association as 
shown by Contingency Coefficient. 
H0 = Survival of the patient is independent of the race to which the patient belongs 
Ha = Survival of the patient is dependent on the race to which the patient belongs 
 
Table.4.17 Statistics for table of Race by Survival code 
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Table.4.18 Cross Tabulation: Race vs Survival code 
 
     Cross tabulation table shows (Table 4.18) it is said that there are 79.50% women that are 
Caucasian, while 11.95 % women are African American. The percentage of women that survived 
who are Caucasian 79.54%, while 78.72% were expired. 11.69 % women survived were African 
American, while 16.49% women expired in that category. Hispanic women constituted 0.87 % 
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out of these 0.92% women survived. While, there are 2.08% women are Asian out of which 
2.13% survived and 1.06 % expired. 
Hypothesis Testing: Survival vs Marital Status 
The next null hypothesis is to find association between the marital status of the patient and 
survival. The null hypothesis in this case is the survival of the patient is independent of marital 
status of the patient. As evidence shows (Table 4.19), the Likelihood Ratio Chi-Square is less 
than the significance level of 5%, so the null hypothesis is rejected. This implies the alternative 
hypothesis is true, survival of the patient is dependent on marital status of the patient. It can be 
thus, concluded that there is an association between survival and marital status.  
H0 = Survival of the patient is independent of marital status of the patient.  
Ha = Survival of the patient is dependent on marital status of the patient. 
Table.4.19 Statistics for table of Marital Status by Survival code 
 
     Cross tabulation table shows (Table 4.20) it is said that there are 46.21% women that are 
Married, while 16.63 % women are Single. The percentage of women that survived who are 
Married 46.60%, while 39.36% were expired. 17.02 % women survived were single, while 9.57% 
women expired in that category. Widowed women constituted 14.27 % out of these 13.71% 
widowed women survived and 24.47% widowed women expired. While, there are 0.08% are 
women who have life partner and 1.15% are legally separated women.  
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 Table.4.20 Cross Tabulation: Marital Status vs Survival code 
Hypothesis Testing: Survival vs Payer Type 
Much research has been done to find patterns or associations between the insurance a patient buys 
and its impact on the survival of the patient. To test the issue the null hypothesis is set to the 
survival of the patient, which is independent of payer type of the patient.  
H0 = Survival of the patient is independent of payer type of the patient.  
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Ha = Survival of the patient is dependent on payer type of the patient. 
As evidence shows (Table 4.21), the chi-square is less than the significance level of 5%, so the 
null hypothesis was rejected. Rejecting the null hypothesis means the alternative hypothesis is 
true. The alternative hypothesis in this case is survival of the patient is dependent on payer type of 
the patient. Thus, there is an association between survival and the payer type of the patient.  
 
Table.4.21 Statistics for table of Payer type by Survival code 
     From the cross tabulation table (Table 4.22) it is said that there are 7.12% women that belong 
have Medicaid as their payer, while 38.16 % women have Medicaid as their payer type. The 
percentage of women that survived who had Medicaid payer were 7.16%, while 5.86% were 
expired. 37.21 % women survived who had Medicare payer, while 55.32 % women expired in 
that category. Blue cross/ Blue Shield constituted 14.55 % of the total payer types out of these 
14.83 % women survived and 9.57% expired. Self-pay has 5.72 % of total out of these 5.77% 
survived and 4.79% expired. 
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Table.4.22 Cross Tabulation: Payer type vs Survival code 
 
Hypothesis Testing: Survival vs Age 
Another hypothesis under consideration is the null hypothesis that the survival of the patient is 
independent of the age of the patient. This null hypothesis was tested by looking at the Likelihood 
Ratio Chi-Square. As evidence shows (Table 4.23), the Likelihood Ratio Chi-Square is less than 
the significance level of 5%, so the null hypothesis is rejected. This implies the alternative 
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hypothesis is true, survival of the patient is dependent on age of the patient. It can be thus, 
concluded that there is an association between survival and age.  
H0 = Survival of the patient is independent of the type of the age of the patient. 
Ha = Survival of the patient is dependent of the type of the age of the patient. 
 
Table.4.23 Statistics for table for Survival vs age of patient 
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Table.4.24 Cross Tabulation: Survival vs age of patient 
 
     From the cross tabulation table (Table 4.24) it is said that there are 27.43% women that belong 
to the age group 58 to 67 years. While the age group 48 to 57 constitutes 22.07% of the total 
patients and 1.26 % belong to 88 to 97. The age group 58 to 67 years has 27.53% patients 
survived, while 25.53% that expired. Age group of 68 to77 has 25.53% women who expired, 
while 21.79 % women who survived.  
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Hypothesis Testing: Survival vs Length of Stay 
    The next null hypothesis is to find an association between the length of stay in the facility by 
the patient and survival. The null hypothesis in this case is survival of the patient is independent 
of the length of stay in the facility by the patient. This null hypothesis was tested by looking at the 
Likelihood Ratio Chi-Square. As evidence shows (Table 4.25), the Likelihood Ratio Chi-Square 
is less than the significance level of 5%, so the null hypothesis is rejected. This implies the 
alternative hypothesis is true, survival of the patient is dependent on length of stay of the patient. 
It can be thus, concluded that there is an association between survival and length of stay of the 
patient.  
H0 = Survival of the patient is independent of the length of stay in the facility by the patient.  
Ha = Survival of the patient is dependent of the length of stay in the facility by the patient.  
Table.4.25 Statistics for table for Survival vs length of stay in the facility by the patient. 
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Table.4.26 Cross Tabulation: Survival vs length of stay 
 
From the cross tabulation table (Table 4.26) it can be said that out of patients who stay in facility 
for 11 to 19 days 20.25% patients expired, while 79.75% patients survived. When patients stay 
for 16 to 27 days in the facility 98.70% women survived on the other hand only 1.30% women 
expired.       
Hypothesis Testing: Survival vs Total Charges 
Another hypothesis under consideration is the null hypothesis that the survival of the patient is 
independent of the total charges a patient is charged. This null hypothesis was tested by looking 
at the Likelihood Ratio Chi-Square. As the evidence shows (Table 4.27), the Likelihood Ratio 
Chi-Square is less than significance level of 5%, so the null hypothesis is rejected. Thus, 
alternative hypothesis is true. It can be said that the survival of the patient is dependent of the 
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total charges a patient is charged. The strength of this association is a weak association, which 
can be stated by the Contingency Coefficient for this test. 
H0 = Survival of the patient is independent of the total charges a patient is charged. 
Ha = Survival of the patient is independent of the total charges a patient is charged 
Table.4.27 Statistics for table for Survival vs total charges 
From the cross tabulation table (Table 4.28) it can be said that out of patients who spend less than 
or equal to $50,000 are 92.29%. 92.98 % survived who paid less than or equal to 10 days, while 
79.79% expired in this category. On the other hand, when patients spent $150,000 -$200,000 
0.22% and 6.25 % women spend $50001 to $100000. 
 
Table.4.28 Cross Tabulation: Survival vs total charges  
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CHAPTER V 
 
 
PREDICTIVE MODELING 
 
 
 
This chapter discusses the findings from predictive modeling technique. The first section 
discusses the results from IBM SPSS Modeler. Three strategies Neural Network- MLP, Neural 
Network- RBF, and Decision tree are compared using the original dataset the unbalanced vs a 
balanced dataset using random over sampling techniques. Thus, the study compares Neural 
Network- MLP using balanced data, Neural Network- RBF using balanced data, and Decision 
tree using balanced data to Neural Network- MLP using unbalanced data, Network- RBF using 
unbalanced data and, Decision tree using unbalanced data. These techniques are compared using 
two different softwares; IBM SPSS modeler and SAS Enterprise Miner 12.3. 
5.1 Balanced Data With IBM SPSS Modeler. 
i. Neural Network: Multilayer Perceptron (MLP) 
Table 4.29 shows results from Neural Network, which uses Radial Basis Function 
(RBF)Procedures. It is a supervised learning technique i.e. they map relationships derived from 
the data. This rotation estimation technique is a model validation technique which uses the 
validation dataset in order to minimize the problem of overfitting. 10 cross fold validation method 
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gives an insight on how the model will generalize on an unknown dataset. Steps involved in cross 
validation are partitioning a sample of data into subsets i.e. in this case 6,574 records are divided 
into subsets. Then analysis is done on one subset at a time after which validation is done on the 
other subsets. In order to reduce variability, there are 10 such rounds or subsets on which cross 
validation is performed using different partitions. The results are then averaged over the subsets. 
Cross validation when compared to the conventional data partitioning technique is better because 
the root mean square error that conventional data partitioning technique generates is not a useful 
estimator of model performance.  
Table.4.29 NN- MLP balanced data using IBM SPSS 
     Thus, the error on the validation dataset does not assess the model performance as well as 
cross validation. Cross validation thus, averages the measures of prediction error to correct while 
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training error and obtain accurate estimates of model performance. In this case, 6,574 is divided 
into roughly 10 equal groups i.e. 4,410 and each of this group has its own model, accuracy, and 
predictors. As we see from the table above, the number of predictors, i.e. 29 are the same 
throughout the 10 groups and so are the number of records 4,410. The best model has an accuracy 
of 99.1% with 29 predictors and the model is tested on 4,410 records. The graph shows (Fig 4.16) 
the predictor importance of this MLP- Neural Network technique. The most important predictor 
for predicting the survival of patients is admission type of the patient i.e. urgent, emergency, etc. 
has a predictor importance of 0.17. The next most important predictor is care-setting type with an 
importance of 0.15. The type of patient admission like inpatient, outpatient, etc. has a predictor 
importance of 0.13. The diagnosis priority i.e. Is ovarian cancer a principal diagnosis or 
secondary diagnosis or so on, has an importance of 0.09. Another parameter with similar 
predictor importance of 0.09 is admission source type i.e. physician referral, clinical referral etc. 
Age of the patient and length of stay have an importance of 0.03. Both of these variables are 
ranked amongst the top ten predictors for survival of ovarian cancer patients using neural 
network- multilayer perceptron technique. 
Fig.4.16 Predictor importance NN- MLP balanced data using IBM SPSS 
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     Table 4.30 (derived from table Appendices) shows the coincidence matrix. It gives an insight 
of the true positives, true negatives, false positives, and false negatives for this particular 
technique. Based on coincidence matrix the accuracy {the ratio between the total numbers of 
correctly classified cases to the overall number of cases under consideration} for the overall 
model is 97.71%. Sensitivity {the proportion of positive cases, which are correctly classified i.e. 
the percentage of patients who expired and classified correctly as expired} 95.47%. Specificity 
{the proportion of negative cases, which are correctly classified i.e. the percentage of patients 
who survived and classified correctly as survived} is 100 %. 
Where AP: Actual Positive, AN: Actual Negative, PP: Predicted Positive, and PN: Predicted 
Negative. 
 
 
 
 
 
Table.4.30 Performance evaluation NN- MLP balanced data using IBM SPSS  
 
ii. Neural Network: Radial Basis Function (RBF)  
Table 4.31 shows results from Neural Network which uses Radial Basis Function (RBF) 
procedures. It is a feed forward supervised learning technique. RBF is used along with rotation 
estimation technique 10 fold cross validation in order to minimize the problem of overfitting. In 
this case 6,574 records are divided into subsets. Then analysis is done on one subset at a time 
after which validation is done on the other subsets. In order to reduce variability, there are 10 
such rounds or subsets on which cross validation is performed using different partitions. The 
results are then averaged over the subsets. Here, the 6,574 records of the balanced dataset are 
 AP AN Total 
PP 1033 0 1033 
PN 49 1061 1110 
Total 1082 1061 2143 
     
Accuracy  0.977135 97.71349   
Sensitivity 0.954713 95.47135   
Specificity 1 100   
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divided into roughly 10 equal groups i.e. 4,410 and each of this group has its own model, 
accuracy, and predictors. As we see from the table above, the number of predictors, i.e. 29 are the 
same throughout the 10 groups and so are the number of records 4,410. The best model has an 
accuracy of 62.5% with 29 predictors and the model is tested on 4,410 records.  
 
Table.4.31 NN- RBF balanced data using IBM SPSS 
 
     Fig.4.17 is the predictor importance of this RBF- Neural Network technique. The most 
important predictor for predicting the survival of patients is census region a patient belongs to i.e. 
South, Midwest, etc. and census division, both having equal predictor importance of 0.14. The 
next most important predictor with an importance of 0.10 is the bed size category of the hospital. 
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The variable present on admit has an importance of 0.09, while care-setting type has an 
importance of 0.07. Using the RBF technique the importance of admission type of the patient has 
decreased from 0.17 in MLP to a 0.05. In addition, the type of patient admission like inpatient, 
outpatient, etc. has decreased its predictor importance from 0.13in MLP to 0.06 in RBF 
technique. However, the type of DRG and MDC code group both of these variables have an 
importance of 0.04 and are amongst the top ten predictors for survival of ovarian cancer patients 
using neural network- radial basis function technique. 
Fig.4.17 Predictor importance NN- RBF balanced data using IBM SPSS 
 
     Table 4.32 (derived from table Appendices) shows the coincidence matrix. Its gives an insight 
of the true positives, true negatives, false positives, and false negatives for this particular 
technique. The accuracy for the overall model is 67.8%, sensitivity 71.62% and specificity 
63.90%.  
 
 
 
 
 
 
 
Table.4.32 Performance evaluation NN- RBF balanced data using IBM SPSS 
 
 AP AN Total 
PP 775 383 1158 
PN 307 678 985 
Total 1082 1061 2143 
     
Accuracy  0.678021 67.80215   
Sensitivity 0.716266 71.62662   
Specificity 0.63902 63.90198   
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i. C5 Decision Tree: 10 fold cross validation 
A C5 decision tree is generated using 10 fold cross validation technique. The depth of the tree is 
14, while cross validation mean is 95.8 with a standard error 0.3. The first leaf of the tree is 
length of stay < =0 and length of stay >0. The first leaf length of stay < =0 has further two leaves 
total charges<= 23239.50 and total charges> 23239.50. Similarly, the tree expands until it has 14 
leaf. The predictor importance for this technique is shown in the graph Fig.4.18.  
Fig.4.18 Predictor importance decision trees balanced data using IBM SPSS 
 
     Using C5 decision tree the most important variable is care-setting type of the patient, which 
has an importance of 0.21. The admission type is the second most important predictor of survival 
with an importance of 0.18. The predictor importance of admission type when compared to the 
other two techniques is higher for MLP 0.17 and for RBF 0.05. While length of stay which was 
amongst the top 10 predictors in MLP is the third most important predictor using decision tree 
with an importance of 0.17. The procedure type i.e. the type of surgery, test etc. conducted on the 
patient has an importance of 0.16. Census region, which was the first most important predictor in 
RBF with importance of 0.14, has an importance of 0.02, which is similar of admission source 
and diagnosis code. 
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     Table 4.33 (derived from table Appendices) calculates the accuracy for the overall model i.e. 
96.07%, sensitivity 92.29% and specificity as 100%.  
 
 
  
 
 
 
Table.4.33 Performance evaluation decision tree balanced data using IBM SPSS 
 
5.2 Unbalanced Data With IBM SPSS Modeler. 
i. Neural Network: Multilayer Perceptron (MLP) 
Table 4.34 shows results from Neural Network, which uses Multilayer Perceptron (MLP) 
procedures. The rotation estimation technique is used to minimize the problem of overfitting. In 
this case, 3,566 records are divided into roughly 10 equal groups i.e. 2,359 and each of this group 
has its own model, accuracy, and predictors. As we see from the table above, the number of 
predictors, i.e. 29 are the same throughout the 10 groups and so are the number of records 2,359. 
The best model has an accuracy of 97.6% with 29 predictors and the model is tested on 2,359 
records.  
 
 
 
 
 AP AN Total 
PP 1018 0 1018 
PN 85 1061 1146 
Total 1103 1061 2164 
     
Accuracy  0.960721 96.07209   
Sensitivity 0.922937 92.29374   
Specificity 1 100   
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Table.4.34 NN- MLP unbalanced data using IBM SPSS 
     The graph Fig.4.19 shows the predictor importance for unbalance data using MLP- Neural 
Network technique.  
Fig.4.19 Predictor importance NN- MLP unbalanced data using IBM SPSS 
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     The most important predictor is care-setting type of the patient, which has an importance of 
0.30. The length of stay is the second most important predictor of survival with an importance of 
0.14 using unbalanced data with MLP technique, length of stay was amongst the top 10 predictors 
in balanced data using MLP is the third most important predictor for balance data using decision 
tree with an importance of 0.17. The predictor importance of admission type when compared to 
the balance data MLP techniques 0.17 and for unbalanced data using MLP it is 0.13. A predictor 
importance of 0.08 is for predicting the survival of patients given admission source of the patient. 
The next most important predictor is the diagnosis priority, which has an importance of 0.07. 
Total charges has an importance of 0.06, while patient type and medical specialty i.e. type of 
doctor attending the patient has an importance of 0.03 Age of the patient has an importance of 
0.02 in this technique. 
Table 4.35 (derived from table Appendices) shows the coincidence matrix. The accuracy for the 
overall model is 94.14%, sensitivity 96.96% and specificity 39.65%. 
 AP AN Total 
PP 1087 35 1122 
PN 34 23 57 
Total 1121 58 1179 
     
Accuracy  0.941476 94.14758   
Sensitivity 0.96967 96.96699   
Specificity 0.396552 39.65517   
 
Table.4.35 Performance evaluation NN- MLP unbalanced data using IBM SPSS 
 
ii. Neural Network: Radial Basis Function (RBF) 
Table 4.36 below shows results from Neural Network which uses Radial Basis Function (RBF) 
procedures. It is a feed forward supervised learning technique. RBF is used along with rotation 
estimation technique 10 fold cross validation in order to minimize the problem of overfitting. In 
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this case, 3,566 records are divided into subsets. These 3,566 records of the unbalanced dataset 
are divided into roughly 10 equal groups i.e. 2,359 and each of this group has its own model, 
accuracy, and predictors. As we see from the table above, the number of predictors, i.e. 29 are the 
same throughout the 10 groups and so are the number of records 2,359. The best model has an 
accuracy of 94.6% with 29 predictors and the model is tested on 2,359 records. 
Table.4.36 NN- RBF unbalanced data using IBM SPSS 
     Fig.4.20 shows the predictor importance of unbalanced data using RBF- Neural Network 
technique. As we see, the graph has all the predictor importance as 0. The variables that graph 
shows are the predictor frequent variables.  
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Fig.4.20 Predictor importance NN- RBF unbalanced data using IBM SPSS 
     However, the performance measurement parameters can give a better insight on the model 
performance. Accuracy for the overall model is 95.08%, sensitivity 100% and specificity 0% 
(table 4.37). 
 
 
 
 
 
 
Table.4.37 Performance evaluation NN- RBF unbalanced data using IBM SPSS 
 
iii. C5 Decision Tree: 10 fold cross validation 
A C5 decision tree is generated using 10 fold cross validation technique. The depth of the tree is 
5, while cross validation mean is 94.4 with a standard error 0.2. The first leaf of the tree is length 
of stay < =6 and length of stay >6. The first leaf length of stay < =0 has further two leaves 
 AP AN Total 
PP 1121 58 1179 
PN 0 0 0 
Total 1121 58 1179 
     
Accuracy  0.950806 95.08058   
Sensitivity 1 100   
Specificity 0 0   
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diagnosis priority (1 to 3) and diagnosis priority (4 and greater). Similarly, the tree expands until 
it has 5 leaf. The predictor importance for this technique is shown in the graph below (Fig.4.21).  
Fig.4.21 Predictor importance decision tree unbalanced data using IBM SPSS 
 
     Using C5 decision tree the most important variable is admission type of the patient, which has 
an importance of 0.48. The length of stay is the second most important predictor of survival with 
an importance of 0.41. While the diagnosis priority has an importance of 0.11. The graph 
(Fig.4.21) only 3 important variables unlike other techniques where there were 10 predictors for 
each technique. Table 4.38 is used to calculate the accuracy for the overall model i.e. 94.86%, 
sensitivity 98.95%, and specificity 16.67%. AP: Actual Positive, AN: Actual Negative, PP: 
Predicted Positive, and PN: Predicted Negative. 
 
 
 
 
 
 
Table.4.38 Performance evaluation decision tree unbalanced data using IBM SPSS 
 
     This part of this chapter discusses the predictive modeling technique findings using SAS 
Enterprise Miner 12.3.  Thus, the results from Neural Network- MLP using balanced data, Neural 
 AP AN Total 
PP 1135 50 1185 
PN 12 10 22 
Total 1147 60 1207 
     
Accuracy  0.948633 94.8633   
Sensitivity 0.989538 98.9538   
Specificity 0.166667 16.6667   
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Network- RBF using balanced data, Decision tree using balanced data , Neural Network- MLP 
using unbalanced data, Network- RBF using unbalanced data and, Decision tree using unbalanced 
data  are discussed below. Later, the best model is evaluated using performance measurement 
technique. 
5.3 Balanced Data With SAS Enterprise Miner 12.3  
i. Neural Network: Multilayer Perceptron (MLP) 
For this study, the inputs for neural network are selected using Stepwise logistic regression. The 
advantage of this technique is to reduce the number of inputs that the neural network would use 
for its analysis. Thus, the first step in this strategy is to perform logistic regression and find useful 
inputs then use those inputs for neural network for this technique the number of inputs are 
reduced to 16 inputs. Neural networks are complex and difficult to explain. These are some of the 
reasons why they are considered black box. This study uses decision tree to explain the outputs 
from neural network since decision tree are simpler to understand and have minimal complexity. 
The tree (Fig.4.22) shows the results from neural network in a tree format.  
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Fig.4.22 Decision tree: NN –MLP balanced data using SAS 
     Depth of the tree for the decision tree above is 8. The tree shows the first split using the 
variable patient type. The tree can be explained by an IF then clause. Given that:   
PATIENT_TYPE_DESC IS ONE OF: RECURRING, OUTPATIENT, OUTPATIENT 
SURGERY, OTHER SPECIALTY, OBSERVATION / SHORT STAY / 24 HR, EMERGENCY, 
SERIES, DAY SURGERY, RADIOLOGY, CLINIC, OBSERVATION or MISSING 
Then, the predicted probability of survival is 0.98 and patient being expired is 0.02. The other leaf 
that could be explained as given the diagnosis_priority >= 4 
AND PATIENT_TYPE_DESC IS ONE OF: INPATIENT, PREADMIT  
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AND ADMISSION_TYPE_CODE_DESC IS ONE OF: ELECTIVE then, the predicted 
probability of survival is 0.24 and patient being expired is 0.76. Similarly, as we go down the tree 
the probabilities vary (see Appendices: Decision tree rules for balanced dataset using neural 
network MLP). Table 4.39 below shows the variable importance for this technique.   
  
Table.4.39 Predictor importance NN- MLP balanced data using SAS 
 
     Table 4.40 can be explained as patient type having an importance of 1 which can be 
considered as the base variable or reference variable. The next most important variable is 
admission type, which has an importance of 0.758 when compared to patient type. Care-setting 
type has an importance of 0.509 i.e. it is 50% less important than patient type. While diagnosis 
priority has an importance of 0.432 and payer type has an importance of 0.255. The next table 
describes the statistics for this model. 
Table.4.40 Statistics for NN- MLP balanced data using SAS  
     Misclassification rate for this model is 0.14 in both training as well as validation data. 
Misclassification occurs when the record or observation belongs to one class, but the model 
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classifies it as a member of another class. For example, misclassification in this study means, a 
patient has survived, but the model classifies it as a member of expired group. The sum of 
squared errors tend to decrease from 950.0 in training dataset to a 477.5 in validation dataset.  
     Table 4.41 is used to calculate the accuracy for the overall model 86.42%, sensitivity 84.59%, 
and specificity 88.35%.  
 
 
 
 
Table.4.41 Performance evaluation NN- MLP balanced data using SAS 
 
Where AP: Actual Positive, AN: Actual Negative, PP: Predicted Positive, and PN: Predicted 
Negative. 
ii. Neural Network: Radial Basis Function (RBF) 
In the input selection step for neural network with radial basis function, there are 16 inputs. The 
tree (Fig.4.23) shows the results from neural network in a tree format. Depth of the tree for the 
decision tree above is 8. The tree shows the first split using the variable patient type. The tree can 
be explained by an IF then clause. Given that: 
 If  PATIENT_TYPE_DESC IS ONE OF: RECURRING, OUTPATIENT, OUTPATIENT 
SURGERY, OTHER SPECIALTY, OBSERVATION / SHORT STAY / 24 HR, EMERGENCY, 
SERIES, DAY SURGERY, RADIOLOGY, CLINIC, OBSERVATION or MISSING  
Then, the predicted probability of survival is 0.98 and patient being expired is 0.02.  
 AP AN Total 
PP 944 123 1067 
PN 172 933 1105 
Total 1116 1056 2172 
     
Accuracy  0.86418 86.418   
Sensitivity 0.845878 84.5878   
Specificity 0.883523 88.3523   
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The other leaf that could be explained as given the  
diagnosis_priority >= 4 AND PATIENT_TYPE_DESC IS ONE OF: INPATIENT, PREADMIT  
AND ADMISSION_TYPE_CODE_DESC IS ONE OF: ELECTIVE given that both of these and 
conditions are fulfilled then, the predicted probability of survival is 0.24 and patient being expired 
is 0.76. Similarly, as we go down the tree the probabilities vary (see Appendices: Decision tree 
rules for balanced dataset using neural network RBF).   
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Fig.4.23 Decision tree:  NN- RBF balanced data using SAS 
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     Table 4.42 below shows the variable importance for this technique. 
  
Table.4.42 Predictor importance NN- RBF balanced data using SAS 
 
     Table 4.43 can be explained as patient type having an importance of 1, which is the base 
variable or reference variable. The next most important variable is admission type, which has an 
importance of 0.758 when compared to patient type. Care-setting type has an importance of 0.509 
i.e. it is 50% less important than patient type. While diagnosis priority has an importance of 0.432 
and payer type has an importance of 0.255. The next table describes the statistics for this model. 
 
Table.4.43 Statistics for NN- RBF balanced data using SAS 
 
     Misclassification rate for this model is 0.14 in both training as well as validation data. While 
the sum of squared errors tend to decrease from 950.0 in training dataset to a 477.5 in validation 
dataset. The results from both of the neural network model seems to be very similar in terms of 
statistics.  
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     Table 4.44 below is used to calculate the accuracy for the overall model 89.25%, sensitivity 
83.42%, and specificity 95.44%. AP: Actual Positive, AN: Actual Negative, PP: Predicted 
Positive, and PN: Predicted Negative. 
 
 
 
 
Table.4.44 Performance evaluation NN- RBF balanced data using SAS 
 
iii. Decision Tree 
The decision tree is used with cross validation technique to minimize overfitting. The tree 
(Fig.4.24) is splitting rules for this tree can be explained using the If then clause. Given that  
 IF admission_source_desc IS ONE OF: PHYSICIAN REFERRAL, CLINIC REFERRAL, 
UNKNOWN or MISSING AND PATIENT_TYPE_DESC IS ONE OF: RECURRING, 
OUTPATIENT, OUTPATIENT SURGERY, OTHER SPECIALTY, OBSERVATION / SHORT 
STAY / 24 HR, EMERGENCY, SERIES, DAY SURGERY, RADIOLOGY, CLINIC, 
OBSERVATION or MISSING  
then, the predicted probability of survival is 1 and patient being expired is 0.00.  
     The other leaf that could be explained as given the  
if caresetting_code_desc IS ONE OF: INTENSIVE CARE UNIT, NOT MAPPED, INTENSIVE 
CARE UNIT - MEDICAL, CORONARY CARE UNIT, INTENSIVE CARE UNIT - 
SURGICAL, UROLOGY AND PATIENT_TYPE_DESC IS ONE OF: INPATIENT, 
PREADMIT 
 AP AN Total 
PP 931 48 979 
PN 185 1008 1193 
Total 1116 1056 2172 
     
Accuracy  0.892577 89.2726   
Sensitivity 0.834229 83.4229   
Specificity 0.954416 95.4545   
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AND ADMISSION_TYPE_CODE_DESC IS ONE OF: URGENT, UNKNOWN, 
EMERGENCY, NEWBORN or MISSING then, the predicted probability of survival is 0.03 and 
patient being expired is 0.97 (see Appendices: Decision tree rules for balanced dataset using 
SAS). 
 
Fig.4.24 Decision tree for balanced data using SAS 
 
     Table 4.45 below shows the variable importance for this technique.   
 
Table.4.45 Predictor importance balanced data: Decision tree 
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     Table 4.46 can be explained as patient type having an importance of 1, which can be 
considered as the base variable or reference variable. The next most important variable is 
admission type, which has an importance of 0.758 when compared to patient type. Care-setting 
type has an importance of 0.57. While diagnosis priority has an importance of 0.432 and age has 
an importance of 0.38. The other variables that hold importance from 0.32 to 0.12 are census 
division where a person belongs, length of stay, payer type, month of admit, admission source 
and the year of admit. The next table describes the statistics for this model. 
 
Table.4.46 Statistics for decision tree balanced data using SAS 
     Misclassification rate for this model is 0.12 in validation data and 0.11 in training data. While 
the sum of squared errors tend to decrease from 670.15 in training dataset to 344.90 in validation 
dataset. Table 4.47 is used to calculate the accuracy for the overall model 87.93%, sensitivity 
79.9%, and specificity 96.40%. AP: Actual Positive, AN: Actual Negative, PP: Predicted 
Positive, and PN: Predicted Negative. 
 
 
 
 
 
Table.4.47 Performance evaluation decision tree balanced data using SAS 
 AP AN Total 
PP 892 38 930 
PN 224 1018 1242 
Total 1116 1056 2172 
     
Accuracy  0.879374 87.9374   
Sensitivity 0.799283 79.9283   
Specificity 0.964015 96.4015   
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5.4 Unbalanced Data With SAS Enterprise Miner 12.3  
i. Neural Network: Multilayer Perceptron (MLP) 
The model selects two inputs after stepwise input selection from logistic regression. Decision tree 
is used to explain the outputs from neural network since decision tree are simpler to understand 
and have minimal complexity. The tree (Fig.4.25) show the results from neural network in a tree 
format. Depth of the tree for the decision tree above is 5. The tree shows the first split using the 
variable patient type. The tree can be explained by an IF then clause. Given that:  
If caresetting_code_desc IS ONE OF: INTENSIVE CARE UNIT, INTENSIVE CARE UNIT - 
MEDICAL, INTENSIVE CARE UNIT - SURGICAL, CORONARY CARE UNIT.  
Then, the predicted probability of survival is 0.14 and patient being expired is 0.86.  
     The other leaf that could be explained as given if caresetting_code_desc IS ONE OF: CARE 
SETTING UNDEFINED, ONCOLOGY, GYNECOLOGY, MULTISPECIALTY UNIT, NOT 
MAPPED, OBSTETRICS, MEDICAL/SURGICAL, SURGERY, OUTPATIENT CLINIC, 
AMBULATORY SURGERY, AMBULAT AND Length_of_stay < 9.5 AND Length_of_stay >= 
5.5. Then the probability of survival is 0.93 and patient being expired is 0.07. Similarly, as we go 
down the tree the probabilities vary (see Appendices: Decision tree rules for unbalanced dataset 
using neural network MLP). 
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Fig.4.25 Decision tree: NN- MLP unbalanced data using SAS  
     Table 4.48 below shows care-setting type having an importance of 1 which is the base variable 
or reference variable. The next most important variable is length of stay, which has an importance 
of 0.453 when compared to care-setting type.  
Table.4.48 Predictor importance NN- MLP unbalanced data using SAS 
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Table.4.49 Statistics for NN- MLP unbalanced data using SAS 
     Table 4.49 shows the statistics for this model. Misclassification rate for this model is 0.04 in 
both training as well as validation data. The sum of squared errors tend to decrease from 162.56 
in training dataset to 88.0 in validation dataset. The table below shows the confusion matrix, for 
training and validation.  
     The accuracy for the overall model 96.18%, sensitivity 99.73%, and specificity 32.26% (table 
4.50). 
 
 
 
 
Table.4.50 Performance evaluation NN- MLP unbalanced data using SAS 
 
Where AP: Actual Positive, AN: Actual Negative, PP: Predicted Positive, and PN: Predicted 
Negative. 
ii. Neural Network: Radial Basis Function (RBF) 
In the input selection step for neural network with radial basis function, there are 2 inputs. The 
tree (fig.2.26) below show the results from neural network in a tree format. Depth of the tree for 
 AP AN Total 
PP 1112 42 1154 
PN 3 20 23 
Total 1115 62 1177 
     
Accuracy  0.961767 96.1767   
Sensitivity 0.997309 99.7309   
Specificity 0.322581 32.2581   
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the decision tree above is 5. The tree shows the first split using the variable patient type. The tree 
can be explained by an IF then clause. Given that: caresetting_code_desc IS ONE OF: 
INTENSIVE CARE UNIT, INTENSIVE CARE UNIT - MEDICAL, INTENSIVE CARE UNIT 
- SURGICAL, CORONARY CARE UNIT. Then, the predicted probability of survival is 0.14 
and patient being expired is 0.86. The other leaf that could be explained as given 
If caresetting_code_desc IS ONE OF: CARE SETTING UNDEFINED, ONCOLOGY, 
GYNECOLOGY, MULTISPECIALTY UNIT, NOT MAPPED, OBSTETRICS, 
MEDICAL/SURGICAL, SURGERY, OUTPATIENT CLINIC, AMBULATORY SURGERY, 
AMBULAT AND Length_of_stay < 9.5 AND Length_of_stay >= 5.5. 
Then the probability of survival is 0.93 and patient being expired is 0.07 (see Appendices: 
Decision tree rules for unbalanced dataset using neural network RBF). 
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Fig.2.26 Decision tree: NN- RBF unbalanced data using SAS 
     Table 4.51 below shows care-setting type having an importance of 1. The next most important 
variable is length of stay, which has an importance of 0.453 when compared to care-setting type.  
   
Table.4.51 Predictor importance NN- RBF unbalanced data using SAS 
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Table.4.52 Statistics for NN- RBF unbalanced data using SAS 
     Misclassification rate for this model (Table 4.52) is 0.04 in both training as well as validation 
data. The sum of squared errors tend to decrease from 162.56 in training dataset to 88.0 in 
validation dataset. 
     The overall accuracy of this model is 96.17%, sensitivity 99.82%, and specificity 30.65% 
(Table 4.53). AP: Actual Positive, AN: Actual Negative, PP: Predicted Positive, and PN: 
Predicted Negative. 
 
 
 
 
 
 
Table.4.53 Performance evaluation NN- RBF unbalanced data using SAS 
 
iii. Decision Tree 
The decision tree is used with cross validation technique to minimize overfitting. The tree 
(Fig.4.27) is splitting rules and it can be explained using the If then clause. Given that  
 AP AN Total 
PP 1113 43 1156 
PN 2 19 21 
Total 1115 62 1177 
     
Accuracy  0.961767 96.1767   
Sensitivity 0.998206 99.8206   
Specificity 0.306452 30.6452   
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IF caresetting_code_desc IS ONE OF: INTENSIVE CARE UNIT, INTENSIVE CARE UNIT - 
MEDICAL, INTENSIVE CARE UNIT - SURGICAL, CORONARY CARE UNIT.  
Then, the predicted probability of survival is 0.14 and patient being expired is 0.86.  
     The other leaf that could be explained as given the  
If caresetting_code_desc IS ONE OF: CARE SETTING UNDEFINED, ONCOLOGY, 
GYNECOLOGY, MULTISPECIALTY UNIT, NOT MAPPED, OBSTETRICS, 
MEDICAL/SURGICAL, SURGERY, OUTPATIENT CLINIC, AMBULATORY SURGERY, 
AMBULAT then, the predicted probability of survival is 0.96 and patient being expired is 0.04 
(see Appendices: Decision tree rules for unbalanced dataset using SAS).   
Fig.4.27 Decision tree unbalanced data using SAS 
 
     Table 4.54 below shows the variable importance for this technique. The model shows only one 
important variable having an importance of 1. 
Table.4.54 Predictor importance Decision tree unbalanced data using SAS 
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     Table 4.55 describes the statistics for this model. Misclassification rate for this model is 0.04 
in both training data and validation data. While the sum of squared errors tend to decrease from 
181.57 in training dataset to 93.42 in validation dataset. 
 
Table.4.55 Statistics for decision tree unbalanced data using SAS 
     Accuracy for the overall model is 95.83%, sensitivity 99.73%, and specificity 25.81% (table 
4.56). AP: Actual Positive, AN: Actual Negative, PP: Predicted Positive, and PN: Predicted 
Negative. 
 
 
 
 
Table.4.56 Performance evaluation decision tree unbalanced data using SAS 
 
     The last step is to evaluate which technique can best predict survival of ovarian cancer 
patients. To determine the best model to using balanced technique used by IBM SPSS modeler, 
using balanced technique used by SAS, using unbalanced technique used by IBM SPSS modeler, 
and using unbalanced technique used by SAS. The best model using SAS (see Appendices: 
Model Comparison: Balanced Data) and balanced technique is neural network radial basis 
 AP AN Total 
PP 1112 46 1158 
PN 3 16 19 
Total 1115 62 1177 
     
Accuracy  0.958369 95.8369   
Sensitivity 0.997309 99.7309   
Specificity 0.258065 25.8065   
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function, the accuracy of the model is 89.27 % which, is followed by Decision tree with an 
accuracy of 87.94% and the last with an accuracy of 86.42% is neural network multilayer 
perceptron (Table 4.57). The best model using IBM SPSS modeler and balanced technique is 
neural network multilayer perceptron, the accuracy of the model is 97.71 % which, is followed by 
Decision tree with an accuracy of 96.07% and the last with an accuracy of 67.80% is neural 
network radial basis function. So the results from both the software are compared it is found that 
IBM SPSS modeler generates a model with better accuracy 97.71 % and cross validated 
results for balanced data.  
Table.4.57 Overall performance evaluation: Balanced data 
     On comparing unbalanced technique used by IBM SPSS modeler, and using unbalanced 
technique used by SAS (Table 4.58). The best model using SAS (see Appendices: Model 
Comparison: Unbalanced Data) and unbalanced technique is neural network radial basis function, 
the accuracy of the model is 96.17 % which, is followed by neural network multilayer perceptron 
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with an accuracy of 96.18% and the last decision tree with an accuracy of 95.84%. The best 
model using IBM SPSS modeler and balanced technique is neural network radial basis function, 
the accuracy of the model is 95.08 % which, is followed by Decision tree with an accuracy of 
94.86% and the last with an accuracy of 94.15% is neural network multilayer perceptron. So the 
results from both the software are compared it is found that SAS generates a model with better 
accuracy 96.17 % for unbalanced data.  
Table.4.58 Overall performance evaluation: Unbalanced data 
 
When both the results of the best models are compared, it is found when an unbalanced data is 
balanced using random over sampling, IBM SPSS modeler tends to generate better results 
with 97.71% accuracy, and if an unbalanced data is, used SAS tends to perform better with 
96.18% accuracy.
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CHAPTER VI 
 
 
CONCLUSION 
 
 
 
This study applies machine learning techniques for predicting ovarian cancer survivability. 
Specifically, the study uses three popular data mining techniques: Neural network- MLP, Neural 
network-RBF and Decision trees. It also provides an insight on the performance of these machine 
learning techniques using a balanced dataset and an imbalanced dataset. The reason behind using 
these machine learning techniques are they have been used in cancer detection and diagnosis for 
nearly 20 years (Simes, 1985). In a real world scenario, most of the cases are imbalanced. Even 
the dataset used in this study was an imbalanced one i.e. the classification categories, were not in 
equal representation i.e. the expired class had only 188 records while survived class had 3,378 
patient records. Machine learning techniques tend to bias the prediction and are thus, a poor 
representation of the minority class. Therefore, it is important to investigate how balanced data 
and imbalanced data perform. The initial number of patient records was 46,792 with 80 factors 
from the Cerner database.  
     After cleansing and transformation, the prediction models are generated with 3,566 patient 
records and 47 variables. This study defines “survival” of ovarian cancer patients as patients who 
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have been completely cured and discharged home. The “discharged home” classifier was chosen 
to mark a completely recovered patient because all other classifiers point to a patient who has not 
fully recovered. This survival was then coded as binary categorical survival variable to represent 
the survival with a value of “1” and non-survival of value “0”. 10-fold cross validation is used in 
all the techniques to minimize the overfitting of models.  Cross validation divides the dataset into 
10 mutually exclusive folds using stratified sampling technique. 9 of 10 folds are used for training 
and the 10th is used for testing. Since it is 10 fold validation, the process is repeated 10 times. In 
this case each of record is once used as part training and once testing. The performance of all the 
10 models is averaged based on the accuracy. This process is repeated for both balanced and 
unbalanced data for all the three techniques to get an unbiased prediction performance.  
     Based on the descriptive statistics this study finds similar patterns that are observed in studies 
conducted on SEER cancer data. The patterns shown by the age of the patient in this study is that 
the average age of a patient is 60 years. Median age of ovarian cancer patients is 63 years. 
Married women show a higher rate of ovarian cancer than single, widowed or divorced women 
do. Based on the race/ ethnicity, Caucasian women show higher chances of having ovarian 
cancer. Most patients visit a facility that is located in urban area than the rural area. Most of these 
facilities that are in urban areas belong to the South region, Northeast region, Midwest region and 
a few in West region. These four census region are further divided into census division where “6” 
South (DE, DC, FL, GA, MD, NC, SC, VA, WV) has the highest concentration of ovarian cancer 
patients i.e. 751. Census Division “2” has the second highest concentration of 513 patients in 
Middle Atlantic (NJ, NY, and PA).  The average length of stay for a patient in the hospital is 3.5 
days. There were 38.16 % Medicare patients, while 14.55 % Blue Cross/ Blue Shield patients and 
7.12% Medicaid patients. 
     The aggregated results indicate that balanced technique using neural network multilayer 
perceptron in IBM SPSS modeler performed the best with a classification accuracy of 97.71% 
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which is better than any other model compared in the study. The second best is using unbalanced 
data on neural network radial basis function with a classification accuracy of 96.18%. The neural 
network with radial basis function comes out as the worst with a classification accuracy of 
67.80% even with a balanced dataset. This signifies given a set of parameters used in the study 
like: admission source, race of the patient, census division and so on the neural network using 
multilayer perceptron will predict the outcome of survival of the patient with 97.71% accuracy. 
The results from this study clearly points out the potential of neural networks classification 
technique.  The advantages of using ANN is they usually perform better than the other models 
due to their complex structures that automatically approximates any non-linear mathematical 
function. They are not sensitive to unusual values (outliers) in the data and thus provide better 
performance.  
     This study predicts ovarian cancer survival using two leading software used for predictive 
modeling SAS Enterprise Miner 9.4 and IBM SPSS 15.0. It is concluded that SAS is very 
efficient source for data management, robust, requires users to have in depth knowledge of 
programming and statistics, generates in depth results at once. While SPSS is more user friendly, 
powerful in graphics, and does not require in depth knowledge about programming. Both of the 
packages have its own strengths and weaknesses. While making decision on what package works 
the best the answer depends on various factors like resources available, cost of the packages, 
knowledge of the user. Therefore, if proper resources are available utilizing both or using mixed 
models depending on the nature of research is recommended.  
     This study also investigates how the predictive modeling techniques perform when unbalanced 
and a balanced dataset is used. From table 4.57 and table 4.58 it is found that prediction accuracy 
of unbalanced data is comparatively low. The classification techniques show poor performance 
while handling an unbalanced data and the results are biased towards the majority class. The 
performance of the models is better when the predictive models have a balanced dataset. The 
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results show with random over sampling the prediction accuracy is best with 97.71%, AUC (Area 
under curve) is sensitivity 0.95 and specificity 1 for neural network MLP. Thus, the best models 
are generated when both the classes are equally represented. To avoid overfitting and increase the 
performance of the classification technique k-fold cross validation can be used along with random 
over sampling technique. In conclusion, a balanced dataset when used along with k-fold cross 
validation to generates best models. 
     In addition to the prediction model, this study also found important factors in order to have a 
better insight into the relative contribution of the variables to predict survivability. Analysis 
indicates the top 15 variables of importance are: 
1. Admission type. 
2. Care-setting type 
3. Patient type. 
4. Diagnosis priority 
5. Length of stay 
6. Bed size category of hospital 
7. Admission source 
8. Procedure type 
9. Census region 
10. Census division 
11. Payer type 
12. MDC code 
13. Age in years 
14. Year of admit 
15. Drg type. 
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     Why these factors are more important predictors than the other is a question that can only be 
answered by medical professional and further clinical studies. This study tries to help find such 
patterns that might be useful in predicting survival and thus not aiming at replacing the valuable 
experience of the medical professionals. 
     A noteworthy strength of this study is that not only does it provide a ranking to the prediction 
models but also variable importance from these techniques. This will help decision makers 
understand what variables are the most important in predicting survival given other features like 
race, payer, admission type and so on. Although data mining methods are useful in pattern 
recognition, help from medical professionals will always provide better depth to the study. These 
medical professionals can use their years of experience to evaluate the patterns found in the study 
and thus categorize these patterns into actionable, logical patterns.  
     Further, scope of the research can be to look into other types of cancer if they influence or 
have correlation with ovarian cancer. Second, are there any medication that influence the survival 
of ovarian cancer patients? Third, further analysis can be conducted on generalizing the software 
package  to be used for analyzing a particular set of data.
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Table.1 Variable attributes
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Table.2 Coincidence matrix for balanced data: Neural Network- MLP 
 
 
 Table.3 Coincidence matrix for balanced data: Neural Network- RBF 
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Table.4 Coincidence matrix for balanced data: C5 Decision tree 
 
Table.5 Coincidence matrix for unbalanced data: Neural Network- MLP 
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Table.6 Coincidence matrix for unbalanced data: Neural Network- RBF 
  
 
Table.7 Coincidence matrix for unbalanced data: C5 Decision tree 
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Table.8 Coincidence matrix for balanced data: Neural Network- MLP 
 
Table.9 Coincidence matrix for balanced data: Neural Network- RBF 
 
Table.10 Coincidence matrix for balanced data: Decision Tree 
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Table.11 Coincidence matrix for unbalanced data: Neural Network- MLP 
 
 
 
Table.12 Coincidence matrix for unbalanced data: Neural Network- RBF 
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Table.13 Coincidence matrix for unbalanced data: Decision Tree
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Decision tree rules for balanced dataset using neural network MLP 
*------------------------------------------------------------* 
 Node = 3 
*------------------------------------------------------------* 
if PATIENT_TYPE_DESC IS ONE OF: RECURRING, OUTPATIENT, OUTPATIENT 
SURGERY, OTHER SPECIALTY, OBSERVATION / SHORT STAY / 24 HR, EMERGENCY, 
SERIES, DAY SURGERY, RADIOLOGY, CLINIC, OBSERVATION or MISSING 
then  
 Tree Node Identifier   = 3 
 Number of Observations = 1047 
 Predicted: Survival_code=1 = 0.98 
 Predicted: Survival_code=0 = 0.02 
  
*------------------------------------------------------------* 
 Node = 9 
*------------------------------------------------------------* 
if diagnosis_priority >= 4 
AND PATIENT_TYPE_DESC IS ONE OF: INPATIENT, PREADMIT 
AND ADMISSION_TYPE_CODE_DESC IS ONE OF: ELECTIVE 
then  
 Tree Node Identifier   = 9 
 Number of Observations = 236 
 Predicted: Survival_code=1 = 0.24 
 Predicted: Survival_code=0 = 0.76 
  
*------------------------------------------------------------* 
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 Node = 10 
*------------------------------------------------------------* 
if caresetting_code_desc IS ONE OF: INTENSIVE CARE UNIT, NOT MAPPED, INTENSIVE 
CARE UNIT - MEDICAL, CORONARY CARE UNIT, INTENSIVE CARE UNIT - 
SURGICAL, UROLOGY 
AND PATIENT_TYPE_DESC IS ONE OF: INPATIENT, PREADMIT 
AND ADMISSION_TYPE_CODE_DESC IS ONE OF: URGENT, UNKNOWN, 
EMERGENCY, NEWBORN or MISSING 
then  
 Tree Node Identifier   = 10 
 Number of Observations = 712 
 Predicted: Survival_code=1 = 0.03 
 Predicted: Survival_code=0 = 0.97 
  
*------------------------------------------------------------* 
 Node = 14 
*------------------------------------------------------------* 
if diagnosis_priority <= 3 or MISSING 
AND caresetting_code_desc IS ONE OF: INTENSIVE CARE UNIT, INTENSIVE CARE UNIT 
- MEDICAL, CORONARY CARE UNIT, INTENSIVE CARE UNIT - SURGICAL, 
AMBULATORY UNIT, OBSTETRICS & GYNECOLOGY 
AND PATIENT_TYPE_DESC IS ONE OF: INPATIENT, PREADMIT 
AND ADMISSION_TYPE_CODE_DESC IS ONE OF: ELECTIVE 
then  
 Tree Node Identifier   = 14 
 Number of Observations = 87 
 Predicted: Survival_code=1 = 0.13 
 Predicted: Survival_code=0 = 0.87 
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*------------------------------------------------------------* 
 Node = 15 
*------------------------------------------------------------* 
if diagnosis_priority <= 3 or MISSING 
AND caresetting_code_desc IS ONE OF: CARE SETTING UNDEFINED, ONCOLOGY, 
GYNECOLOGY, NOT MAPPED, OBSTETRICS, MEDICAL/SURGICAL, SURGERY, 
AMBULATORY SURGERY, NURSING HOME (LTC), ONCOLOGY - GYNECOLOGY, 
ORT 
AND PATIENT_TYPE_DESC IS ONE OF: INPATIENT, PREADMIT 
AND ADMISSION_TYPE_CODE_DESC IS ONE OF: ELECTIVE 
then  
 Tree Node Identifier   = 15 
 Number of Observations = 791 
 Predicted: Survival_code=1 = 0.86 
 Predicted: Survival_code=0 = 0.14 
  
*------------------------------------------------------------* 
 Node = 21 
*------------------------------------------------------------* 
if caresetting_code_desc IS ONE OF: CARE SETTING UNDEFINED, ONCOLOGY, 
MEDICAL/SURGICAL, MULTISPECIALTY UNIT, SURGERY, CARDIOLOGY, 
EMERGENCY ROOM, ONCOLOGY - GYNECOLOGY, ORTHOPEDICS, PEDIATRICS, 
NOT A, 
AND PATIENT_TYPE_DESC IS ONE OF: INPATIENT, PREADMIT 
AND ADMISSION_TYPE_CODE_DESC IS ONE OF: EMERGENCY, NEWBORN or 
MISSING 
then  
 Tree Node Identifier   = 21 
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 Number of Observations = 884 
 Predicted: Survival_code=1 = 0.21 
 Predicted: Survival_code=0 = 0.79 
  
*------------------------------------------------------------* 
 Node = 32 
*------------------------------------------------------------* 
if payer_code_desc IS ONE OF: MEDICARE, HMO/MANAGED CARE (UNDESIGNATED), 
BLUE CROSS/BLUE SHIELD, MEDICAID, MEDICAID MANAGED CARE (UNDESIGNA, 
MEDICARE MANAGED CARE (UNDESIGNA, OTHER GOVERNMENT 
AND caresetting_code_desc IS ONE OF: CARE SETTING UNDEFINED, ONCOLOGY, 
MEDICAL/SURGICAL, MULTISPECIALTY UNIT, SURGERY, CARDIOLOGY, 
EMERGENCY ROOM, ONCOLOGY - GYNECOLOGY, ORTHOPEDICS, PEDIATRICS, 
NOT A 
AND PATIENT_TYPE_DESC IS ONE OF: INPATIENT, PREADMIT 
AND ADMISSION_TYPE_CODE_DESC IS ONE OF: URGENT, UNKNOWN 
then  
 Tree Node Identifier   = 32 
 Number of Observations = 539 
 Predicted: Survival_code=1 = 0.36 
 Predicted: Survival_code=0 = 0.64 
  
*------------------------------------------------------------* 
 Node = 33 
*------------------------------------------------------------* 
if payer_code_desc IS ONE OF: PPO (UNDESIGNATED), OTHER COMMERCIAL PAYER, 
OTHER NON-GOVT, SELF-PAY or MISSING 
AND caresetting_code_desc IS ONE OF: CARE SETTING UNDEFINED, ONCOLOGY, 
MEDICAL/SURGICAL, MULTISPECIALTY UNIT, SURGERY, CARDIOLOGY, 
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EMERGENCY ROOM, ONCOLOGY - GYNECOLOGY, ORTHOPEDICS, PEDIATRICS, 
NOT A 
AND PATIENT_TYPE_DESC IS ONE OF: INPATIENT, PREADMIT 
AND ADMISSION_TYPE_CODE_DESC IS ONE OF: URGENT, UNKNOWN 
then  
 Tree Node Identifier   = 33 
 Number of Observations = 106 
 Predicted: Survival_code=1 = 0.83 
 Predicted: Survival_code=0 = 0.17 
Decision tree rules for balanced dataset using neural network RBF 
*------------------------------------------------------------* 
 Node = 3 
*------------------------------------------------------------* 
if PATIENT_TYPE_DESC IS ONE OF: RECURRING, OUTPATIENT, OUTPATIENT 
SURGERY, OTHER SPECIALTY, OBSERVATION / SHORT STAY / 24 HR, EMERGENCY, 
SERIES, DAY SURGERY, RADIOLOGY, CLINIC, OBSERVATION or MISSING 
then  
 Tree Node Identifier   = 3 
 Number of Observations = 1047 
 Predicted: Survival_code=1 = 0.98 
 Predicted: Survival_code=0 = 0.02 
  
*------------------------------------------------------------* 
 Node = 9 
*------------------------------------------------------------* 
if diagnosis_priority >= 4 
AND PATIENT_TYPE_DESC IS ONE OF: INPATIENT, PREADMIT 
AND ADMISSION_TYPE_CODE_DESC IS ONE OF: ELECTIVE 
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then  
 Tree Node Identifier   = 9 
 Number of Observations = 236 
 Predicted: Survival_code=1 = 0.24 
 Predicted: Survival_code=0 = 0.76 
  
*------------------------------------------------------------* 
 Node = 10 
*------------------------------------------------------------* 
if caresetting_code_desc IS ONE OF: INTENSIVE CARE UNIT, NOT MAPPED, INTENSIVE 
CARE UNIT - MEDICAL, CORONARY CARE UNIT, INTENSIVE CARE UNIT - 
SURGICAL, UROLOGY 
AND PATIENT_TYPE_DESC IS ONE OF: INPATIENT, PREADMIT 
AND ADMISSION_TYPE_CODE_DESC IS ONE OF: URGENT, UNKNOWN, 
EMERGENCY, NEWBORN or MISSING 
then  
 Tree Node Identifier   = 10 
 Number of Observations = 712 
 Predicted: Survival_code=1 = 0.03 
 Predicted: Survival_code=0 = 0.97 
  
*------------------------------------------------------------* 
 Node = 14 
*------------------------------------------------------------* 
if diagnosis_priority <= 3 or MISSING 
AND caresetting_code_desc IS ONE OF: INTENSIVE CARE UNIT, INTENSIVE CARE UNIT 
- MEDICAL, CORONARY CARE UNIT, INTENSIVE CARE UNIT - SURGICAL, 
AMBULATORY UNIT, OBSTETRICS & GYNECOLOGY 
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AND PATIENT_TYPE_DESC IS ONE OF: INPATIENT, PREADMIT 
AND ADMISSION_TYPE_CODE_DESC IS ONE OF: ELECTIVE 
then  
 Tree Node Identifier   = 14 
 Number of Observations = 87 
 Predicted: Survival_code=1 = 0.13 
 Predicted: Survival_code=0 = 0.87 
  
*------------------------------------------------------------* 
 Node = 15 
*------------------------------------------------------------* 
if diagnosis_priority <= 3 or MISSING 
AND caresetting_code_desc IS ONE OF: CARE SETTING UNDEFINED, ONCOLOGY, 
GYNECOLOGY, NOT MAPPED, OBSTETRICS, MEDICAL/SURGICAL, SURGERY, 
AMBULATORY SURGERY, NURSING HOME (LTC), ONCOLOGY - GYNECOLOGY, 
ORT 
AND PATIENT_TYPE_DESC IS ONE OF: INPATIENT, PREADMIT 
AND ADMISSION_TYPE_CODE_DESC IS ONE OF: ELECTIVE 
then  
 Tree Node Identifier   = 15 
 Number of Observations = 791 
 Predicted: Survival_code=1 = 0.86 
 Predicted: Survival_code=0 = 0.14 
  
*------------------------------------------------------------* 
 Node = 21 
*------------------------------------------------------------* 
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if caresetting_code_desc IS ONE OF: CARE SETTING UNDEFINED, ONCOLOGY, 
MEDICAL/SURGICAL, MULTISPECIALTY UNIT, SURGERY, CARDIOLOGY, 
EMERGENCY ROOM, ONCOLOGY - GYNECOLOGY, ORTHOPEDICS, PEDIATRICS, 
NOT A, 
AND PATIENT_TYPE_DESC IS ONE OF: INPATIENT, PREADMIT 
AND ADMISSION_TYPE_CODE_DESC IS ONE OF: EMERGENCY, NEWBORN or 
MISSING 
then  
 Tree Node Identifier   = 21 
 Number of Observations = 884 
 Predicted: Survival_code=1 = 0.21 
 Predicted: Survival_code=0 = 0.79 
  
*------------------------------------------------------------* 
 Node = 32 
*------------------------------------------------------------* 
if payer_code_desc IS ONE OF: MEDICARE, HMO/MANAGED CARE (UNDESIGNATED), 
BLUE CROSS/BLUE SHIELD, MEDICAID, MEDICAID MANAGED CARE (UNDESIGNA, 
MEDICARE MANAGED CARE (UNDESIGNA, OTHER GOVERNMENT 
AND caresetting_code_desc IS ONE OF: CARE SETTING UNDEFINED, ONCOLOGY, 
MEDICAL/SURGICAL, MULTISPECIALTY UNIT, SURGERY, CARDIOLOGY, 
EMERGENCY ROOM, ONCOLOGY - GYNECOLOGY, ORTHOPEDICS, PEDIATRICS, 
NOT A 
AND PATIENT_TYPE_DESC IS ONE OF: INPATIENT, PREADMIT 
AND ADMISSION_TYPE_CODE_DESC IS ONE OF: URGENT, UNKNOWN 
then  
 Tree Node Identifier   = 32 
 Number of Observations = 539 
 Predicted: Survival_code=1 = 0.36 
 Predicted: Survival_code=0 = 0.64 
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*------------------------------------------------------------* 
 Node = 33 
*------------------------------------------------------------* 
if payer_code_desc IS ONE OF: PPO (UNDESIGNATED), OTHER COMMERCIAL PAYER, 
OTHER NON-GOVT, SELF-PAY or MISSING 
AND caresetting_code_desc IS ONE OF: CARE SETTING UNDEFINED, ONCOLOGY, 
MEDICAL/SURGICAL, MULTISPECIALTY UNIT, SURGERY, CARDIOLOGY, 
EMERGENCY ROOM, ONCOLOGY - GYNECOLOGY, ORTHOPEDICS, PEDIATRICS, 
NOT A 
AND PATIENT_TYPE_DESC IS ONE OF: INPATIENT, PREADMIT 
AND ADMISSION_TYPE_CODE_DESC IS ONE OF: URGENT, UNKNOWN 
then  
 Tree Node Identifier   = 33 
 Number of Observations = 106 
 Predicted: Survival_code=1 = 0.83 
 Predicted: Survival_code=0 = 0.17 
 
Decision tree rules for balanced dataset using Decision tree 
 
*------------------------------------------------------------* 
 Node = 7 
*------------------------------------------------------------* 
if admission_source_desc IS ONE OF: PHYSICIAN REFERRAL, CLINIC REFERRAL, 
UNKNOWN or MISSING 
AND PATIENT_TYPE_DESC IS ONE OF: RECURRING, OUTPATIENT, OUTPATIENT 
SURGERY, OTHER SPECIALTY, OBSERVATION / SHORT STAY / 24 HR, EMERGENCY, 
SERIES, DAY SURGERY, RADIOLOGY, CLINIC, OBSERVATION or MISSING 
then  
 Tree Node Identifier   = 7 
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 Number of Observations = 1003 
 Predicted: Survival_code=1 = 1.00 
 Predicted: Survival_code=0 = 0.00 
  
*------------------------------------------------------------* 
 Node = 10 
*------------------------------------------------------------* 
if caresetting_code_desc IS ONE OF: INTENSIVE CARE UNIT, NOT MAPPED, INTENSIVE 
CARE UNIT - MEDICAL, CORONARY CARE UNIT, INTENSIVE CARE UNIT - 
SURGICAL, UROLOGY 
AND PATIENT_TYPE_DESC IS ONE OF: INPATIENT, PREADMIT 
AND ADMISSION_TYPE_CODE_DESC IS ONE OF: URGENT, UNKNOWN, 
EMERGENCY, NEWBORN or MISSING 
then  
 Tree Node Identifier   = 10 
 Number of Observations = 712 
 Predicted: Survival_code=1 = 0.03 
 Predicted: Survival_code=0 = 0.97 
  
*------------------------------------------------------------* 
 Node = 12 
*------------------------------------------------------------* 
if census_division IS ONE OF: 5 
AND admission_source_desc IS ONE OF: EMERGENCY ROOM, TRANSFER FROM A 
SKILLED NURSING 
AND PATIENT_TYPE_DESC IS ONE OF: RECURRING, OUTPATIENT, OUTPATIENT 
SURGERY, OTHER SPECIALTY, OBSERVATION / SHORT STAY / 24 HR, EMERGENCY, 
SERIES, DAY SURGERY, RADIOLOGY, CLINIC, OBSERVATION or MISSING 
then  
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 Tree Node Identifier   = 12 
 Number of Observations = 23 
 Predicted: Survival_code=1 = 0.13 
 Predicted: Survival_code=0 = 0.87 
  
*------------------------------------------------------------* 
 Node = 13 
*------------------------------------------------------------* 
if census_division IS ONE OF: 4, 1 or MISSING 
AND admission_source_desc IS ONE OF: EMERGENCY ROOM, TRANSFER FROM A 
SKILLED NURSING 
AND PATIENT_TYPE_DESC IS ONE OF: RECURRING, OUTPATIENT, OUTPATIENT 
SURGERY, OTHER SPECIALTY, OBSERVATION / SHORT STAY / 24 HR, EMERGENCY, 
SERIES, DAY SURGERY, RADIOLOGY, CLINIC, OBSERVATION or MISSING 
then  
 Tree Node Identifier   = 13 
 Number of Observations = 21 
 Predicted: Survival_code=1 = 1.00 
 Predicted: Survival_code=0 = 0.00 
  
*------------------------------------------------------------* 
 Node = 16 
*------------------------------------------------------------* 
if diagnosis_priority >= 4 
AND age_in_years < 55.5 
AND PATIENT_TYPE_DESC IS ONE OF: INPATIENT, PREADMIT 
AND ADMISSION_TYPE_CODE_DESC IS ONE OF: ELECTIVE 
then  
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 Tree Node Identifier   = 16 
 Number of Observations = 23 
 Predicted: Survival_code=1 = 1.00 
 Predicted: Survival_code=0 = 0.00 
  
*------------------------------------------------------------* 
 Node = 22 
*------------------------------------------------------------* 
if year IS ONE OF: 2011, 2010, 2008, 2005, 2006, 2013 
AND diagnosis_priority <= 3 or MISSING 
AND caresetting_code_desc IS ONE OF: INTENSIVE CARE UNIT, INTENSIVE CARE UNIT 
- MEDICAL, CORONARY CARE UNIT, INTENSIVE CARE UNIT - SURGICAL, 
AMBULATORY UNIT, OBSTETRICS & GYNECOLOGY 
AND PATIENT_TYPE_DESC IS ONE OF: INPATIENT, PREADMIT 
AND ADMISSION_TYPE_CODE_DESC IS ONE OF: ELECTIVE 
then  
 Tree Node Identifier   = 22 
 Number of Observations = 81 
 Predicted: Survival_code=1 = 0.06 
 Predicted: Survival_code=0 = 0.94 
  
*------------------------------------------------------------* 
 Node = 23 
*------------------------------------------------------------* 
if year equals Missing 
AND diagnosis_priority <= 3 or MISSING 
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AND caresetting_code_desc IS ONE OF: INTENSIVE CARE UNIT, INTENSIVE CARE UNIT 
- MEDICAL, CORONARY CARE UNIT, INTENSIVE CARE UNIT - SURGICAL, 
AMBULATORY UNIT, OBSTETRICS & GYNECOLOGY 
AND PATIENT_TYPE_DESC IS ONE OF: INPATIENT, PREADMIT 
AND ADMISSION_TYPE_CODE_DESC IS ONE OF: ELECTIVE 
then  
 Tree Node Identifier   = 23 
 Number of Observations = 6 
 Predicted: Survival_code=1 = 1.00 
 Predicted: Survival_code=0 = 0.00 
  
*------------------------------------------------------------* 
 Node = 26 
*------------------------------------------------------------* 
if diagnosis_priority >= 4 
AND caresetting_code_desc IS ONE OF: CARE SETTING UNDEFINED, ONCOLOGY, 
INTENSIVE CARE UNIT, NOT MAPPED, NURSING HOME (LTC), ORTHOPEDICS, 
INTENSIVE CARE UNIT - NEUROLOGY 
AND age_in_years >= 55.5 or MISSING 
AND PATIENT_TYPE_DESC IS ONE OF: INPATIENT, PREADMIT 
AND ADMISSION_TYPE_CODE_DESC IS ONE OF: ELECTIVE 
then  
 Tree Node Identifier   = 26 
 Number of Observations = 203 
 Predicted: Survival_code=1 = 0.11 
 Predicted: Survival_code=0 = 0.89 
  
*------------------------------------------------------------* 
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 Node = 27 
*------------------------------------------------------------* 
if diagnosis_priority >= 4 
AND caresetting_code_desc equals Missing 
AND age_in_years >= 55.5 or MISSING 
AND PATIENT_TYPE_DESC IS ONE OF: INPATIENT, PREADMIT 
AND ADMISSION_TYPE_CODE_DESC IS ONE OF: ELECTIVE 
then  
 Tree Node Identifier   = 27 
 Number of Observations = 10 
 Predicted: Survival_code=1 = 1.00 
 Predicted: Survival_code=0 = 0.00 
  
*------------------------------------------------------------* 
 Node = 32 
*------------------------------------------------------------* 
if payer_code_desc IS ONE OF: MEDICARE, HMO/MANAGED CARE (UNDESIGNATED), 
BLUE CROSS/BLUE SHIELD, MEDICAID, MEDICAID MANAGED CARE (UNDESIGNA, 
MEDICARE MANAGED CARE (UNDESIGNA, OTHER GOVERNMENT 
AND caresetting_code_desc IS ONE OF: CARE SETTING UNDEFINED, ONCOLOGY, 
MEDICAL/SURGICAL, MULTISPECIALTY UNIT, SURGERY, CARDIOLOGY, 
EMERGENCY ROOM, ONCOLOGY - GYNECOLOGY, ORTHOPEDICS, PEDIATRICS, 
NOT A 
AND PATIENT_TYPE_DESC IS ONE OF: INPATIENT, PREADMIT 
AND ADMISSION_TYPE_CODE_DESC IS ONE OF: URGENT, UNKNOWN 
then  
 Tree Node Identifier   = 32 
 Number of Observations = 539 
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 Predicted: Survival_code=1 = 0.36 
 Predicted: Survival_code=0 = 0.64 
  
*------------------------------------------------------------* 
 Node = 33 
*------------------------------------------------------------* 
if payer_code_desc IS ONE OF: PPO (UNDESIGNATED), OTHER COMMERCIAL PAYER, 
OTHER NON-GOVT, SELF-PAY or MISSING 
AND caresetting_code_desc IS ONE OF: CARE SETTING UNDEFINED, ONCOLOGY, 
MEDICAL/SURGICAL, MULTISPECIALTY UNIT, SURGERY, CARDIOLOGY, 
EMERGENCY ROOM, ONCOLOGY - GYNECOLOGY, ORTHOPEDICS, PEDIATRICS, 
NOT A 
AND PATIENT_TYPE_DESC IS ONE OF: INPATIENT, PREADMIT 
AND ADMISSION_TYPE_CODE_DESC IS ONE OF: URGENT, UNKNOWN 
then  
 Tree Node Identifier   = 33 
 Number of Observations = 106 
 Predicted: Survival_code=1 = 0.83 
 Predicted: Survival_code=0 = 0.17 
  
*------------------------------------------------------------* 
 Node = 38 
*------------------------------------------------------------* 
if diagnosis_priority <= 3 or MISSING 
AND caresetting_code_desc IS ONE OF: CARE SETTING UNDEFINED, ONCOLOGY, 
GYNECOLOGY, NOT MAPPED, OBSTETRICS, MEDICAL/SURGICAL, SURGERY, 
AMBULATORY SURGERY, NURSING HOME (LTC), ONCOLOGY - GYNECOLOGY, 
ORT 
AND age_in_years < 66.5 or MISSING 
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AND PATIENT_TYPE_DESC IS ONE OF: INPATIENT, PREADMIT 
AND Length_of_stay < 10.5 or MISSING 
AND ADMISSION_TYPE_CODE_DESC IS ONE OF: ELECTIVE 
then  
 Tree Node Identifier   = 38 
 Number of Observations = 475 
 Predicted: Survival_code=1 = 1.00 
 Predicted: Survival_code=0 = 0.00 
  
*------------------------------------------------------------*  
 Node = 39 
*------------------------------------------------------------* 
if diagnosis_priority <= 3 or MISSING 
AND caresetting_code_desc IS ONE OF: CARE SETTING UNDEFINED, ONCOLOGY, 
GYNECOLOGY, NOT MAPPED, OBSTETRICS, MEDICAL/SURGICAL, SURGERY, 
AMBULATORY SURGERY, NURSING HOME (LTC), ONCOLOGY - GYNECOLOGY, 
ORT 
AND age_in_years < 66.5 or MISSING 
AND PATIENT_TYPE_DESC IS ONE OF: INPATIENT, PREADMIT 
AND Length_of_stay >= 10.5 
AND ADMISSION_TYPE_CODE_DESC IS ONE OF: ELECTIVE 
then  
 Tree Node Identifier   = 39 
 Number of Observations = 29 
 Predicted: Survival_code=1 = 0.31 
 Predicted: Survival_code=0 = 0.69 
  
*------------------------------------------------------------* 
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 Node = 40 
*------------------------------------------------------------* 
if diagnosis_priority <= 3 or MISSING 
AND census_division IS ONE OF: 2, 3, 5 or MISSING 
AND caresetting_code_desc IS ONE OF: CARE SETTING UNDEFINED, ONCOLOGY, 
GYNECOLOGY, NOT MAPPED, OBSTETRICS, MEDICAL/SURGICAL, SURGERY, 
AMBULATORY SURGERY, NURSING HOME (LTC), ONCOLOGY - GYNECOLOGY, 
ORT 
AND age_in_years >= 66.5 
AND PATIENT_TYPE_DESC IS ONE OF: INPATIENT, PREADMIT 
AND ADMISSION_TYPE_CODE_DESC IS ONE OF: ELECTIVE 
then  
 Tree Node Identifier   = 40 
 Number of Observations = 163 
 Predicted: Survival_code=1 = 0.44 
 Predicted: Survival_code=0 = 0.56 
  
*------------------------------------------------------------* 
 Node = 41 
*------------------------------------------------------------* 
if diagnosis_priority <= 3 or MISSING 
AND census_division IS ONE OF: 6, 4, 7, 8, 1, 9 
AND caresetting_code_desc IS ONE OF: CARE SETTING UNDEFINED, ONCOLOGY, 
GYNECOLOGY, NOT MAPPED, OBSTETRICS, MEDICAL/SURGICAL, SURGERY, 
AMBULATORY SURGERY, NURSING HOME (LTC), ONCOLOGY - GYNECOLOGY, 
ORT 
AND age_in_years >= 66.5 
AND PATIENT_TYPE_DESC IS ONE OF: INPATIENT, PREADMIT 
AND ADMISSION_TYPE_CODE_DESC IS ONE OF: ELECTIVE 
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then  
 Tree Node Identifier   = 41 
 Number of Observations = 124 
 Predicted: Survival_code=1 = 1.00 
 Predicted: Survival_code=0 = 0.00 
  
*------------------------------------------------------------* 
 Node = 52 
*------------------------------------------------------------* 
if diagnosis_code_desc IS ONE OF: MALIGNANT NEOPLASM OF OVARY, MALIGNANT 
NEOPLASM OF PARAMETRIU 
AND caresetting_code_desc IS ONE OF: CARE SETTING UNDEFINED, CARDIOLOGY, 
EMERGENCY ROOM, NOT A CARE SETTING, PULMONOLOGY 
AND PATIENT_TYPE_DESC IS ONE OF: INPATIENT, PREADMIT 
AND ADMISSION_TYPE_CODE_DESC IS ONE OF: EMERGENCY, NEWBORN or 
MISSING 
then  
 Tree Node Identifier   = 52 
 Number of Observations = 726 
 Predicted: Survival_code=1 = 0.14 
 Predicted: Survival_code=0 = 0.86 
  
*------------------------------------------------------------* 
 Node = 53 
*------------------------------------------------------------* 
if diagnosis_code_desc equals Missing 
AND caresetting_code_desc IS ONE OF: CARE SETTING UNDEFINED, CARDIOLOGY, 
EMERGENCY ROOM, NOT A CARE SETTING, PULMONOLOGY 
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AND PATIENT_TYPE_DESC IS ONE OF: INPATIENT, PREADMIT 
AND ADMISSION_TYPE_CODE_DESC IS ONE OF: EMERGENCY, NEWBORN or 
MISSING 
then  
 Tree Node Identifier   = 53 
 Number of Observations = 7 
 Predicted: Survival_code=1 = 1.00 
 Predicted: Survival_code=0 = 0.00 
  
*------------------------------------------------------------* 
 Node = 54 
*------------------------------------------------------------* 
if caresetting_code_desc IS ONE OF: ONCOLOGY, MEDICAL/SURGICAL, 
MULTISPECIALTY UNIT, SURGERY, ORTHOPEDICS, STEP-DOWN UNIT or MISSING 
AND age_in_years < 79.5 or MISSING 
AND PATIENT_TYPE_DESC IS ONE OF: INPATIENT, PREADMIT 
AND ADMISSION_TYPE_CODE_DESC IS ONE OF: EMERGENCY, NEWBORN or 
MISSING 
then  
 Tree Node Identifier   = 54 
 Number of Observations = 95 
 Predicted: Survival_code=1 = 0.69 
 Predicted: Survival_code=0 = 0.31 
  
*------------------------------------------------------------* 
 Node = 55 
*------------------------------------------------------------* 
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if caresetting_code_desc IS ONE OF: ONCOLOGY, MEDICAL/SURGICAL, 
MULTISPECIALTY UNIT, SURGERY, ORTHOPEDICS, STEP-DOWN UNIT or MISSING 
AND age_in_years >= 79.5 
AND PATIENT_TYPE_DESC IS ONE OF: INPATIENT, PREADMIT 
AND ADMISSION_TYPE_CODE_DESC IS ONE OF: EMERGENCY, NEWBORN or 
MISSING 
then  
 Tree Node Identifier   = 55 
 Number of Observations = 56 
 Predicted: Survival_code=1 = 0.07 
 Predicted: Survival_code=0 = 0.93 
 
Decision tree rules for unbalanced dataset using neural network MLP 
------------------------------------------------------------* 
 Node = 2 
*------------------------------------------------------------* 
if caresetting_code_desc IS ONE OF: INTENSIVE CARE UNIT, INTENSIVE CARE UNIT - 
MEDICAL, INTENSIVE CARE UNIT - SURGICAL, CORONARY CARE UNIT 
then  
 Tree Node Identifier   = 2 
 Number of Observations = 43 
 Predicted: Survival_code=1 = 0.14 
 Predicted: Survival_code=0 = 0.86 
  
*------------------------------------------------------------* 
 Node = 7 
*------------------------------------------------------------* 
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if caresetting_code_desc IS ONE OF: CARE SETTING UNDEFINED, ONCOLOGY, 
GYNECOLOGY, MULTISPECIALTY UNIT, NOT MAPPED, OBSTETRICS, 
MEDICAL/SURGICAL, SURGERY, OUTPATIENT CLINIC, AMBULATORY SURGERY, 
AMBULAT 
AND Length_of_stay < 9.5 AND Length_of_stay >= 5.5 
then  
 Tree Node Identifier   = 7 
 Number of Observations = 299 
 Predicted: Survival_code=1 = 0.93 
 Predicted: Survival_code=0 = 0.07 
  
*------------------------------------------------------------* 
 Node = 8 
*------------------------------------------------------------* 
if caresetting_code_desc IS ONE OF: NOT MAPPED 
AND Length_of_stay >= 9.5 
then  
 Tree Node Identifier   = 8 
 Number of Observations = 9 
 Predicted: Survival_code=1 = 0.22 
 Predicted: Survival_code=0 = 0.78 
  
*------------------------------------------------------------* 
 Node = 9 
*------------------------------------------------------------* 
if caresetting_code_desc IS ONE OF: CARE SETTING UNDEFINED, ONCOLOGY, 
MEDICAL/SURGICAL, SURGERY, ONCOLOGY - GYNECOLOGY or MISSING 
AND Length_of_stay >= 9.5 
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then  
 Tree Node Identifier   = 9 
 Number of Observations = 149 
 Predicted: Survival_code=1 = 0.82 
 Predicted: Survival_code=0 = 0.18 
  
*------------------------------------------------------------* 
 Node = 10 
*------------------------------------------------------------* 
if caresetting_code_desc IS ONE OF: CARE SETTING UNDEFINED, ONCOLOGY, 
GYNECOLOGY, MULTISPECIALTY UNIT, NOT MAPPED, OBSTETRICS, 
MEDICAL/SURGICAL, SURGERY, OUTPATIENT CLINIC, AMBULATORY SURGERY, 
AMBULAT 
AND Length_of_stay < 0.5 or MISSING 
then  
 Tree Node Identifier   = 10 
 Number of Observations = 964 
 Predicted: Survival_code=1 = 1.00 
 Predicted: Survival_code=0 = 0.00 
  
*------------------------------------------------------------* 
 Node = 11 
*------------------------------------------------------------* 
if caresetting_code_desc IS ONE OF: CARE SETTING UNDEFINED, ONCOLOGY, 
GYNECOLOGY, MULTISPECIALTY UNIT, NOT MAPPED, OBSTETRICS, 
MEDICAL/SURGICAL, SURGERY, OUTPATIENT CLINIC, AMBULATORY SURGERY, 
AMBULAT 
AND Length_of_stay < 5.5 AND Length_of_stay >= 0.5 
then  
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 Tree Node Identifier   = 11 
 Number of Observations = 925 
 Predicted: Survival_code=1 = 0.97 
 Predicted: Survival_code=0 = 0.03 
 
Decision tree rules for unbalanced dataset using neural network RBF 
*------------------------------------------------------------* 
 Node = 2 
*------------------------------------------------------------* 
if caresetting_code_desc IS ONE OF: INTENSIVE CARE UNIT, INTENSIVE CARE UNIT - 
MEDICAL, INTENSIVE CARE UNIT - SURGICAL, CORONARY CARE UNIT 
then  
 Tree Node Identifier   = 2 
 Number of Observations = 43 
 Predicted: Survival_code=1 = 0.14 
 Predicted: Survival_code=0 = 0.86 
  
*------------------------------------------------------------* 
 Node = 7 
*------------------------------------------------------------* 
if caresetting_code_desc IS ONE OF: CARE SETTING UNDEFINED, ONCOLOGY, 
GYNECOLOGY, MULTISPECIALTY UNIT, NOT MAPPED, OBSTETRICS, 
MEDICAL/SURGICAL, SURGERY, OUTPATIENT CLINIC, AMBULATORY SURGERY, 
AMBULAT 
AND Length_of_stay < 9.5 AND Length_of_stay >= 5.5 
then  
 Tree Node Identifier   = 7 
 Number of Observations = 299 
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 Predicted: Survival_code=1 = 0.93 
 Predicted: Survival_code=0 = 0.07 
  
*------------------------------------------------------------* 
 Node = 8 
*------------------------------------------------------------* 
if caresetting_code_desc IS ONE OF: NOT MAPPED 
AND Length_of_stay >= 9.5 
then  
 Tree Node Identifier   = 8 
 Number of Observations = 9 
 Predicted: Survival_code=1 = 0.22 
 Predicted: Survival_code=0 = 0.78 
  
*------------------------------------------------------------* 
 Node = 9 
*------------------------------------------------------------* 
if caresetting_code_desc IS ONE OF: CARE SETTING UNDEFINED, ONCOLOGY, 
MEDICAL/SURGICAL, SURGERY, ONCOLOGY - GYNECOLOGY or MISSING 
AND Length_of_stay >= 9.5 
then  
 Tree Node Identifier   = 9 
 Number of Observations = 149 
 Predicted: Survival_code=1 = 0.82 
 Predicted: Survival_code=0 = 0.18 
  
*------------------------------------------------------------* 
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 Node = 10 
*------------------------------------------------------------* 
if caresetting_code_desc IS ONE OF: CARE SETTING UNDEFINED, ONCOLOGY, 
GYNECOLOGY, MULTISPECIALTY UNIT, NOT MAPPED, OBSTETRICS, 
MEDICAL/SURGICAL, SURGERY, OUTPATIENT CLINIC, AMBULATORY SURGERY, 
AMBULAT 
AND Length_of_stay < 0.5 or MISSING 
then  
 Tree Node Identifier   = 10 
 Number of Observations = 964 
 Predicted: Survival_code=1 = 1.00 
 Predicted: Survival_code=0 = 0.00 
  
*------------------------------------------------------------* 
 Node = 11 
*------------------------------------------------------------* 
if caresetting_code_desc IS ONE OF: CARE SETTING UNDEFINED, ONCOLOGY, 
GYNECOLOGY, MULTISPECIALTY UNIT, NOT MAPPED, OBSTETRICS, 
MEDICAL/SURGICAL, SURGERY, OUTPATIENT CLINIC, AMBULATORY SURGERY, 
AMBULAT 
AND Length_of_stay < 5.5 AND Length_of_stay >= 0.5 
then  
 Tree Node Identifier   = 11 
 Number of Observations = 925 
 Predicted: Survival_code=1 = 0.97 
 Predicted: Survival_code=0 = 0.03 
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Decision tree rules for unbalanced dataset using decision tree 
 
Node = 2 
*------------------------------------------------------------* 
if caresetting_code_desc IS ONE OF: INTENSIVE CARE UNIT, INTENSIVE CARE UNIT - 
MEDICAL, INTENSIVE CARE UNIT - SURGICAL, CORONARY CARE UNIT 
then  
 Tree Node Identifier   = 2 
 Number of Observations = 43 
 Predicted: Survival_code=1 = 0.14 
 Predicted: Survival_code=0 = 0.86 
  
*------------------------------------------------------------* 
 Node = 3 
*------------------------------------------------------------* 
if caresetting_code_desc IS ONE OF: CARE SETTING UNDEFINED, ONCOLOGY, 
GYNECOLOGY, MULTISPECIALTY UNIT, NOT MAPPED, OBSTETRICS, 
MEDICAL/SURGICAL, SURGERY, OUTPATIENT CLINIC, AMBULATORY SURGERY, 
AMBULAT 
then  
 Tree Node Identifier   = 3 
 Number of Observations = 2346 
 Predicted: Survival_code=1 = 0.96 
 Predicted: Survival_code=0 = 0.04 
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Model Comparison: Balanced Data 
 
 
 
 
 
154 
 
  
 
Model Comparison: UnBalanced Data 
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